Role of cardiac magnetic resonance in clinic and arrhytmic prognostic  risk assesment in non-ischemic heart diseases by De Lazzari, Manuel
   
      
 
 
Sede Amministrativa: Università degli Studi di Padova 
 
Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari 
___________________________________________________________________ 
 
CORSO DI DOTTORATO DI RICERCA IN: SCIENZE MEDICHE, CLINICHE E SPERIMENTALI  
CURRICOLO: SCIENZE CARDIOVASCOLARI 
CICLO 29° 
 
 
 
ROLE OF CARDIAC MAGNETIC RESONANCE  
IN CLINIC AND ARRHYTHMIC PROGNOSTIC RISK 
ASSESSMENT IN NON-ISCHEMIC HEART DISEASES  
 
 
 
 
 
Coordinatore: Ch.mo Prof. Gaetano THIENE 
Supervisore: Ch.mo Prof. Martina PERAZZOLO MARRA 
 
 
       Dottorando: Dott. Manuel DE LAZZARI 
          
 
 
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
 
 
 
Ensinar é mostrar que é possível. Aprender é tornar possível a si 
mesmo. 
P. Coelho,  O diario de um mago 
 
 
“Teaching is only demonstrating that it is possible. Learning is making it possible for yourself.” 
P. Coelho, The Pilgrimage 
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ABSTRACT 
 
 
Currently, many diagnostic tools are available in the clinical arena helping 
physicians to achieve a diagnosis in non-ischemic heart diseases and now, the 
main issue is change into prognostic assessment both clinical and, above all, 
arrhythmic. 
Cardiac magnetic resonance (CMR) has emerged as a clinically applicable and 
highly reproducible non-invasive imaging technique and so used extensively over 
the last years. Its value in term of diagnosis is well known and recently 
investigations are aimed at prognostic purposes and risk stratification. Many 
studies analyzed the impact of a scar as detected in vivo by contrast-CMR in 
hypertrophic cardiomyopathy in term of death and ventricular arrhythmias. The 
same concept was proved for dilated cardiomyopathy identifying a midwall stria 
as an adverse prognostic marker of cardiovascular death, arrhythmias and less 
robust marker of heart failure hospitalization. Junctional type of scar was 
investigated in hypertrophic cardiomyopathy and in right ventricle hypertrophy 
due to pulmonary artery hypertension, no data concerning its value in dilated 
cardiomyopathy are reported so far. This learning may be transferred into other 
kind of heart diseases.    
Cardiac magnetic resonance tissue characterization doesn’t deal with scar only 
but also with myocardial tissue edema. Myocardial edema was been strongly 
studied in acute myocardial infarction in term of area at risk, savage myocardium 
and to detect hemorrhagic myocardial infarct, but prognostic data regarding 
other heart diseases are missing.  
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The aims of our studies were the followings: 
1. to evaluate the presence and the prevalence of junctional LGE in patient 
with dilated cardiomyopathy, the possible relationship between junctional 
LGE and hemodynamic data and the prognostic significance of this pattern 
in terms of specific endpoints (arrhythmic and heart failure outcome) in 
opposite of other type of LGE. In order to investigate this hypothesis, data 
disclosed in the clinical studio have been proved by ex vivo studies. 
2. To evaluate the relationship between myocardial edema as evidenced by 
CMR and electrocardiographic data (T-wave inversion) in a series of 
consecutive patients admitted for clinically suspected acute myocarditis. 
Moreover, to evaluate the prognostic value of T wave inversion (as 
myocardial edema marker) during the acute/subacute disease phase in 
predicting LV  dysfunction during follow-up. 
3. To evaluate the presence of a myocardial substrate underlying life-
threatening arrhythmias in young adults with mitral valve prolapse. In 
order to investigate this hypothesis, data collected in the clinical studio 
have been proved by pathological (ex vivo) study. 
4. Since the proof of the relationship between ventricular arrhythmias and 
scar in specific area of left ventricle in mitral valve patients, to evaluate the 
morphological features of mitral valve apparatus underling arrhythmic 
mitral valve prolapse with fibrosis. In order to confirm these observations, 
data disclosed by the clinical study have been related by ex vivo results in 
the pathologic study. 
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Chapter 1 
 
BACKGROUND 
 
Cardiac Magnetic Resonance 
Cardiac magnetic resonance (CMR) is a non-invasive imaging modality 
allowing not only for highly accurate quantification of right and left ventricular 
volumes and function, but also for myocardial tissue characterization, including 
differentiation of myocardial edema and necrosis/fibrosis, which may otherwise 
remain unrecognized (1). Furthermore, there is growing evidence delineating the 
strength and additive value of CMR in identifying patients at risk for sudden 
cardiac death (SCD) in all cardiomyopathies, beyond other traditional risk factors 
as ejection fraction (2). 
The volumes and function information are obtained by steady state free 
precession sequences, the methods of choice for cine imaging. They allow high 
signal-noise ratio and excellent contrast between myocardium and blood pool. 
These features lead to an easy morphologic and functional analysis. 
The most widespread used technique to detect myocardial edema are T2-
weighted sequences even if they can have potential pitfalls that might be known 
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and recognized to avoid a misleading interpretation. Incomplete blood 
suppression with dark-blood techniques, regional variations in signal intensity 
from coil inhomogeneities, and signal loss from myocardial contraction and 
relaxation during acquisition are significant challenges for this technique in 
clinical practice. Thanks to recent technical developments (i.e. turbo inversion 
recovery magnitude sequences, Figure 1A) such challenges can be overcome  
most of the time. The special relevance that myocardial edema assessment has in 
a lot of clinical settings makes these information essential. Nowadays mapping 
techniques seem to be more accurate than classical T2-weighted  but not 
widespread available (1).  
The technique of late gadolinium enhancement (LGE) to detect myocardial 
scar/fibrosis (Figure 1B) was developed more than one decade ago and validated 
with histopathologic correlation (3). Gadolinium is an intravascular medium of 
contrast which can diffuse in the interstitial space following a pathologic insult. 
These agents have paramagnetic properties, and as such, they modify tissue 
properties that directly affect T1 and T2 signal intensities on CMR. As a 
consequence, contrast agents yield a bright signal in the damaged areas where 
they accumulate compared to normal myocardium on delayed post contrast 
imaging. From LGE distribution, we can recognize several “pattern” of LGE: a spot 
pattern if the area of LGE is small and focal, “patchy” if there are multiple 
irregular foci of LGE, “stria” if the area of LGE has a linear shape like a band and 
“transmural” if the LGE is involving the whole thickness of myocardium wall (4).  
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Figure 1; T2-weighted sequence to detect myocardial edema. Note the presence of myocardial 
edema in the epicardial layer of left ventricle lateral wall (A, white arrow); Delayed post 
contrast image (LGE) to detect myocardial fibrosis/necrosis. Note the presence of myocardial 
necrosis in the epicardial layer of left ventricle infero-lateral wall (B, arrow).  
 
 
 
 
Current clinical application 
In current clinical practice, CMR plays a central role in the diagnostic and 
decision making process in several cardiac disease/pathologies, including acute 
and chronic ischemic heart diseases, dilated cardiomyopathy, hypertrophic 
cardiomyopathy, acute myocarditis, infiltrative disease and cardiac masses.  
 
Cardiac Magnetic Resonance has an expanding role also in prognostic risk 
assessment. The LGE (with a stria pattern, Figure 2A) in dilated cardiomyopathy is 
a promising predictor of cardiac death and ventricular tachycardia (5) even if in 
order to validate a biomarker as best predictor a vast multicenter clinical trial is 
needed. A recent meta-analysis showed that patients with LGE had increased 
overall mortality (odds ratio, 3.27; P<0.001), heart failure hospitalization (odds 
ratio, 2.91; P=0.02), and SCD/aborted SCD (odds ratio, 5.32; P<0.001) compared 
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with those without LGE (2). In the hypertrophic cardiomyopathy, left ventricle 
(LV) scar (Figure 2B) is demonstrated an independent predictor of inducible 
ventricular tachycardia, SCD (7,8), or cardiac death (9).  
In Arrhythmogenic Ventricular Cardiomyopathy CMR plays an important role 
as diagnostic tool, even if so far the post contrast findings are not considered in 
current task force criteria (Figure 2C). Notwithstanding, post contrast imaging is 
an essential technique to identify an associated LV involvement or a left dominant 
disease. Finally the presence of LGE is associated with a high prevalence of 
appropriate ICD therapy and SCD reaching 48% (10). 
 
 
 
 
Figure 2.  CMR post contrast images of (A) dilated cardiomyopathy with mid wall fibrosis stria 
(white arrow); (B) hypertrophic cardiomyopathy, note the black area (arrow head) within the 
LGE area (white arrow) corresponding to preserved isolated myocardium or microvascular 
damage; Arrhythmogenic cardiomyopathy (C) with fibrosis involving both right ventricle and 
interventricular septum, (arrows). 
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Chapter 2  
 
COMPREHENSIVE AIMS 
  
 
If the added clinical and prognostic value of tissue characterization endorsed 
by CMR is well known in several cardiomyopathies as previously described, some 
aspects of dilated cardiomyopathy and myocarditis as well as some old concepts 
regarding the challenging risk assessment in mitral valve prolapse are missing. I.e. 
the value of a focal LGE spot along the interventricular septum junctional points is 
not yet assessed in dilated cardiomyopathy. In acute myocarditis, the meaning 
about the prognostic value of negative T-wave is not studied, even this ECG 
pattern is considered benign in acute ischemic heart disease and in apical 
ballooning syndrome hence it might be represent an underlying transient 
myocardial edema. Finally, detection of myocardial scar may benefit the 
challenging risk assessment of mitral valve prolapse patients as seem to be true 
for non ischemic cardiomyopathy as described before.     
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The aims of our researches are to investigate the role of CMR in clinical and 
arrhythmic risk assessment in non ischemic heart disease such as:  
 
- dilated cardiomyopathy focusing in the junctional pattern of LGE in 
opposition to classical stria, evaluating its prognostic role since analyzed its 
prevalence and the relationship with hemodynamic data obtained by 
simultaneous heart catheterization (Chapter 3).   
- acute clinically suspected myocarditis focusing in myocardial edema as 
substrate of negative T waves and its implications in the follow up (Chapter 
4) 
- mitral valve prolapse focusing in the substrates associated with ventricular 
arrhythmias (Chapter 5 and 6). 
 
Regarding the junctional pattern in dilated cardiomyopathy and the anatomic-
morphological features of left ventricle and mitral valve annulus in mitral valve 
prolapse, the in vivo analysis performed by CMR have been compared with ex vivo 
pathologic and histopathologic studies. 
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Chapter 3 
 
THE DIFFERENT PROGNOSTIC ROLE OF 
FIBROSIS IN DILATED CARDIOMYOPATHY.  
Is not just a matter of Late Enhancement 
 
3.1 Introduction 
Dilated cardiomyopathy (DCM) is a common heart muscle disease, which is 
responsible for approximately one-third of the heart failure (HF) (11,12). Life- 
threating arrhythmias and sudden cardiac death (SCD) account for 30% of all 
fatalities in this kind of patients (13). Current risk stratification for SCD and 
indication to implant an ICD rely on reduction of LV (left ventricle) ejection 
fraction (EF), which is a recognized poor marker of ventricular electrical instability 
(14-16). Clinic-pathologic correlation studies have showed that the presence of 
myocardial fibrosis may provide a substrate for malignant ventricular arrhythmias 
and SCD (17,18). 
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As highlighted in the section before, CMR with LGE is a well established 
noninvasive tool that has the ability to accurately identify and quantify ventricular 
myocardial fibrosis (19). Previous CMR studies in patients with DCM have 
demonstrated that ventricular LGE heralds an adverse prognosis with regard to 
death and/or composite end point (i.e. heart failure-related hospitalization, 
arrhythmias). Also our group published a study designed with the aim of evaluate 
the role of the presence and the extent of LV LGE for predicting major arrhythmic 
events and SCD in a large population of patients with DCM diagnosed according 
to the WHO criteria (6). By study design, the hemodynamic patient profile 
encompassed the entire disease spectrum including subjects with severe LV 
dysfunction who meet criteria for ICD implantation and those with mild or 
moderate disease forms who did not. Dilated cardiomyopathy was classified as 
“non-ischemic” by coronary angiography findings, which is consistent with 
current clinical practice and allows the most accurate etiology definition for 
clinical research purposes. The major study results were that: 1) presence of LV-
LGE is a powerful and independent predictor of arrhythmic outcome during a 
median follow-up period of 3 years; 2) presence of LV-LGE appeared to be 
superior in predicting major arrhythmic events and SCD to traditional LV EF ≤35%; 
3) the absence of LGE characterized a low arrhythmic subgroup of patients with 
no SCD events over the follow-up. A sub-analysis of our data failed in disclosing an 
association between LGE and heart failure outcome. In the same year, Kuruvilla et 
al (2) published a metanalysis including 9 studies with a total of 1,488 patients 
and a mean follow-up of 30 months. Patients with LGE had increased overall 
mortality (OR 3.27, p<0.001) and an increased risk of SCD/aborted SCD (OR 5.32, 
p<0.001) when compared with those without LGE. Also the HF hospitalization was 
assessed but with a lower estimated odd ratio (OR 2.91, p=0.02) but, as the same 
authors declared, with a wide heterogeneity among the studies.  
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Of note, also the presence and extent of pulmonary hypertension (PH) is a 
well-established prognostic factor in heart failure (HF) in terms of increased 
mortality and hospitalization rates (20-24). At least two thirds of patients with 
severe LV systolic dysfunction have PH with associated right ventricular (RV) 
failure, and mortality in this group is 2-folder higher in comparison with isolated 
LV dysfunction (22). Hence, the potent prognostic impact of PH in HF suggests an 
important role for pre-clinical detection of signs indicating an ongoing RV 
dysfunction due to its remodeling.   
The presence of a new pattern of LGE along the right ventricle (RV) 
junctional insertion point of the interventricular septum was recently described 
by CMR in patients with pulmonary artery hypertension (PAH). This pattern, the 
so-called junctional LGE was present in the majority of these patients (25-31), 
associated with a RV hypertrophy due to pulmonary artery pressure overload. 
These studies suggested a significant inverse correlation between the degree of 
junctional RV LGE and hemodynamics. The hypothesized mechanisms underlying 
junctional LGE in PAH includes myocardial ischemia, hypoxia, fibrosis, and 
mechanical wall stress, leading to the development of local fibrosis in those 
places where the RV muscular stress is unloaded and we can speculate that 
junctional LGE is related to gadolinium pooling within these area.  
So far, a junctional type LGE pattern has been found beyond PAH, in other clinical 
conditions such as hypertrophic cardiomyopathy (32), congenital heart disease 
with RV overload (33,34), dilated cardiomyopathy (alone or associated with 
diffuse mid-wall LGE) (35,36), and moreover in endurance athletes (37). The 
association between hemodynamic parameters and junctional LGE have been 
studied in PH only in the setting of a precapillary PAH, characterized by a normal 
pulmonary capillary wedge pressure (PCWP) (25,31), and no data have been 
reported i.e. in patients with DCM and severe impairment of LV systolic function, 
characterized by end diastolic LV pressure overload/post capillary pulmonary 
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hypertension (Group 2) (38). If it could be demonstrated that junctional LGE 
pattern correlate with a worst hemodynamic parameters in term of end-diastolic 
LV pressure and/or post capillary pulmonary artery pressure, it will be a marker of  
incipient heart failure than other classical LGE pattern already analyzed (i.e. 
midwall stria, epicardic stria, patchy).  
 
3.2 Aims 
The aims of our study were: 1) to evaluate the presence and the prevalence 
of junctional LGE in patient with DCM, 2) to evaluate the possible relationship 
between LGE and hemodynamics obtained by a simultaneously right side 
catheterization, and 3) to evaluate the prognostic significance of this pattern in 
terms of major events and specific arrhythmic and heart failure outcome in 
opposite of other type of LGE. 
 
 
3.3 Methods 
 
Study population design  
The present study included a consecutive series of patients referred to our 
clinic with diagnosis of DCM, based on the 1995 WHO/International Society and 
Federation of Cardiology criteria (39). To be enrolled, patients had to have 1) a 
reduced LV systolic function (LV EF <50%) on echo; 2) an angiographic study 
showing the absence of flow-limiting coronary artery disease (defined as ≥ 50% 
luminal stenosis on coronary angiography); 3) the absence of either valvular or 
hypertensive heart disease and congenital heart abnormalities. 
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Exclusion criteria were: recent onset of heart failure (<1 month); diagnosis 
of hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic 
right ventricular cardiomyopathy, suspected infiltrative heart disease or other 
specific cardiomyopathies; contraindication to CMR (claustrophobia, pacemaker, 
implantable cardioverter defibrillator  ICD, metallic clips, atrial fibrillation, severe 
obesity preventing the patient from entering the scanner bore; pregnancy); 
chronic renal failure with an estimated glomerular filtration rate < 30 ml/min. All 
subjects underwent a comprehensive diagnostic work-up including 12-leads 
electrocardiogram, echocardiography, biochemistry, CMR and cardiac 
catheterization (including coronary angiography), during the same hospitalization. 
The institutional review board approved the study, and all patients gave their 
informed consent. 
 
Cardiac Catheterization  
Diagnostic right heart catheterization was performed using a Swan-Ganz® 
Standard Thermodilution Catheters (Edwards Lifesciences) within 24 hours of 
CMR execution. The following measurements were obtained: mean right atrial 
pressure (RAP), systolic and end-diastolic right ventricular pressures, pulmonary 
artery systolic, mean and diastolic pressure (PASP, PAMP and PADP, respectively), 
and pulmonary capillary wedge pressures (PCWP). Blood samples for estimation 
of oxygen saturation were drawn from the superior and inferior caval veins, as 
well as right atrium, and that from the pulmonary and femoral arteries were used 
for screening for intra-cardiac shunts. Cardiac output was determined by 
thermodilution. Pulmonary vascular resistance (PVR) was calculated from the 
equation PAMP-PCWP (trans-pulmonary gradient) divided by cardiac output (CO). 
Using a pigtail catheter placed into the LV, LV end-diastolic pressure (LVEDP) was 
recorded. According with current guidelines (38), PH is definited as a PAMP ≥25 
mmHg at rest, pre-capillary PH as PCWP is ≤15 mmHg, post-capillary PH as PCWP 
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>15 mmHg. Combinated post capillary and pre-capillary PH if the diastolic 
pressure gradient (definited as PADP – PCWP) ≥9 mmHg (38). 
 
Cardiac Magnetic Resonance scan protocol and analysis 
Cardiac magnetic resonance scan was performed on a 1.5-Tesla scanner 
(Magnetom Avanto, Siemens Medical Solutions, Erlangen, Germany). All patients 
underwent detailed CMR study protocol including post-contrast sequences. 
Images were acquired using a steady-state free precession sequence (true FISP) 
cine loops in sequential short axis views and 3 long- axis views. 
After intravenous administration of contrast agent 2-dimensional segmented fast 
low-angle shot inversion recovery sequence after at least 10 minutes were 
acquired in the same views of cine images, covering the entire ventricles 
Inversion times were adjusted to null normal myocardium (typically 220-300 
msec) and images were repeated in 2 separate phase-encoding directions to 
exclude artefacts (see Appendix section for details). 
Global ventricular volumes, systolic function and LV myocardial mass were 
calculated from the short-axis cine images, excluding papillary muscles from the 
myocardium, using a dedicated software (CMR42, Circle Cardiovascular Imaging 
Inc). The presence, location and extent of LGE were assessed by two experienced 
observers who were blinded to clinical data and outcome; ambiguous cases were 
reviewed using a third expert.  To exclude artefact, LGE was deemed present only 
if visible in two orthogonal views (short-axis and long-axis). To detect junctional 
LGE distinguishing from RV cavity or interventricular fat, post-contrast images  
were compared with balance steady-state free precession using frames acquired 
in the same position and in the same cardiac phase. Myocardial LGE was 
quantified by a semiautomatic detection and LGE mass (in grams) expressed as a 
percentage of total LV mass, according to previously validated methods (40) LGE 
was quantified using a signal intensity threshold of >3SD above a remote 
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reference region (41-44). The pattern of LGE distribution was characterized as 
either epicardial, mid-wall or patchy/junctional (35,36,42). Patients initially 
diagnosed as having DCM displaying a subendocardial or transmural pattern of 
LGE suggestive of myocardial infarction were excluded from the final analysis.  
 
Follow up  
The follow-up data were obtained prospectively during regular outpatient 
visits at 3, 6, 12,18 and 24 months. All events were adjudicated by the consensus 
of an independent committee blinded to the CMR results. The events collected 
were: hospitalization for decompensated heart failure (requiring inotropic and 
diuretics infusions), cardiac death/heart transplantation/ventricular assist devices 
and ventricular arrhythmias (composite by sustained ventricular tachycardia, 
sudden cardiac death, aborted sudden death, appropriate ICD intervention).  
A 24-h ECG-Holter monitoring was obtained for each patient without ICD every 6 
months. Routine ICD interrogation (at 1, 3 and 6 months, and every 6 months 
thereafter) and ECG recordings at the time of symptoms were used to document 
the occurrence of spontaneous ventricular tachycardia (VT) during follow-up. 
Sudden death was defined as any natural death occurring instantaneously or 
within one hour from symptoms onset. Sustained VT was defined as tachycardia 
originating in the ventricle with rate >100 beats/minute and lasting >30 seconds 
or requiring an intervention for termination. Appropriate ICD intervention was 
defined as a device shock or anti-tachycardia overdrive pacing delivered in 
response to a ventricular tachyarrhythmia and documented by stored intracardiac 
ECG data.  
 
Statistical Analysis  
Data are expressed as mean value ± standard deviation or median with 25 
to 75 percentiles for normally distributed and skewed variables, respectively. 
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Normal distribution was assessed by Kolmogorov-Smirnov test. Differences 
between categorical variables were evaluated by the chi-square test or the Fisher 
exact test as appropriate. Categorical variable are expressed as percentiles. Paired 
and unpaired t test were used to compare normally distributed continuous 
variables respectively obtained from the same patient and different patients; 
paired and unpaired Rank Sum test were used for skewed continuous variables. 
Regression analysis models were conducted on blocks of variables until regression 
final model with only significant variables were obtained in order to evaluate the 
independent predictive value of functional and hemodynamic parameters.  
Kaplan-Meier analysis was used to estimate the survival distributions.  Cox model 
was used to identify predictors of events during follow up. Linear regression was 
used to assess the correlation between the 2 independent observes performing 
LGE planimetry. A p value <0.05 was considered significant. Statistics were 
analysed with SPSS version 19 (SPSS Inc, Chicago, IL). 
 
 
3.4 Results 
 
Baseline characteristics 
A total of 144 with DCM were consecutively evaluated; 8 refused or had 
contra-indication to contrast-enhanced CMR and 5 did not perform right heart 
catheterization within 24-hours so these patients were finally excluded. Four 
patients were lost over the follow-up. The remaining 127 patients (97 men, 
median age 49 years) fulfilling the enrolment criteria constituted the final study 
population.  
On the basis of LGE findings, out of 127 patients, 48 (38%) showed junctional LGE.  
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Table 1 shows baselines clinical characteristics of the enrolled patients. Thirty-one 
patients (24%) had a family history of DCM; 59 patients (47%) had a history of 
chronic HF. At the time of CMR, the majority of patients were NYHA class I or II 
and received a heart failure drug therapy, including angiotensin-converting 
enzyme Inhibitor (ACEI) or angiotensin II receptor blockers (ARB) (92%), and ß-
blockers (94%). No differences on baseline characteristics were found between 
patients with or without junctional LGE. 
 
Cardiac magnetic resonance findings 
On morpho-functional CMR, the majority of patients (73%) showed an EF 
minor than 35% (median EF value 29%) (Table 1). No differences on LV and RV 
dimension were found between patients with or without junctional LGE. In the 
junctional LGE group, the patients had reduced RV EF (51% vs 57%, p<.001) and 
LV EF (27% vs 30%, p=0.003).  
On post-contrast images, 58 (46%) patients had a midwall stria or a spot 
pattern of LGE. Contrast LGE was observed in the RV junctions (at the level of RV 
insertion points with septum) in 48 (38%) patients: in 17/48 patients LGE was 
confined only to the junctions points in 29/48 patients the junctional LGE was 
associated with mid-wall interventricular septal stria and 2 patient had junctional 
LGE associated with mid-wall stria on lateral free LV wall. Twenty-seven patients 
showed mid-wall/spot LGE pattern without junctional involvement. 
The median extent of LGE was 2% [0-10%] of LV mass in the overall 
population. Among patients with LGE, the median extent of LGE was 10% [3-14%] 
and the median extent of junctional LGE was 1% [0-2%] of LV mass. 
Linear regression analysis showed a high correlation between the 2 observers for 
planimetry of %LGE (r=0.95, p <0.01). 
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Table 1. Baseline characteristics of overall sample and according to results of Late 
Gadolinium Enhancement. 
 Overall 
sample 
n = 127 
Junctional LGE 
present 
n = 48 
Junctional LGE 
absent 
n = 79 
p 
Age (years) 49 (37-61) 49 (37-62) 49 (33-60) 0.423 
Male sex, No. (%) 97 (76) 37 (77) 60 (76) 0.884 
Family history of DCM, No. (%) 31 (24) 13 (27) 18 (23) 0.585 
Chronic heart failure  
(> 6 months), No. (%) 
59 (47) 22 (46) 37 (47) 0.913 
LBBB, No. (%) 43 (34) 16 (33) 27 (34) 0.922 
NYHA class, No. (%) 
I-II 
III-IV 
 
82 (65) 
45 (35) 
 
32 (67) 
16 (33) 
 
50 (63) 
29 (37) 
 
0.700 
0.700 
Medications, No. (%) 
ACEI or ARB therapy 
ß-blockers 
Spironolactone 
Diuretic 
Amiodarone 
Digoxin 
 
117 (92) 
119 (94) 
70 (55) 
93 (73) 
20 (16) 
18 (14) 
 
42 (88) 
45 (94) 
31 (65) 
38 (79) 
9 (19) 
9 (19) 
 
75 (95) 
74 (94) 
39 (49) 
55 (70) 
11 (14) 
9 (11) 
 
0.176 
0.762 
0.106 
0.321 
0.506 
0.265 
NTproBNP (ng/L) 770 (381-1942) 1161 (694-3901) 662 (217-1487) 0.004 
CMR 
LV EDV (mL/m2) 
LV EF (%) 
LV EF< 35%, No. (%) 
RV EDV (mL/m2) 
RV EF (%) 
 
113 (93-147) 
29 (24-37) 
93 (73) 
90 (82-100) 
55 (48-60) 
 
111 (99-148) 
27 (21-33) 
39 (81) 
93 (82-118) 
51 (45-56) 
 
113 (93-147) 
30 (25-38) 
54 (68) 
88 (83-97) 
57 (52-61) 
 
0.542 
0.033 
0.112 
0.189 
<0.001 
LGE= Late Gadolinium Enhancement; DCM = Dilated Cardiomyopathy; EF= Ejection Fraction; 
EDV = End-Diastolic Volume; NYHA = New York Heart Association; ACE= Angiotensin-Converting 
Enzyme Inhibitors; ARB= Angiotensin II Receptor Blocker; LBBB = Left Bundle Branch Block; 
CMR= Cardiac Magnetic Resonance;  
Categorical variables are presented as number of patients (%). Continuous values are 
expressed as median with 25% and 75%-iles. 
 
 
Right heart catheterization hemodynamic and delayed enhancement 
Right heart side catheterization demonstrated pulmonary hypertension, 
defined as a PAMP >25 mmHg, in 58 patients (46%) (Table 2); the majority of 
subjects showed increased LVEDP (69%) and 53% had increased PCWP. Patients 
with junctional LGE showed a worse hemodynamic profile in terms of pulmonary 
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hypertension (58% vs 38%; p=0.026), an increased value of PCWP (71% vs 42%; 
p=0.001) and LVEDP (88% vs 58%; p=0.001). According with the current European 
Society of Cardiology guidelines, among patients with PH with high PCWP, 54/58 
patients had a combined post capillary and precapillary PH  (Diastolic Pressure 
Gradient ≥7 mmHg). 
In the junctional LGE group, a slight greater value of RAP (mean 6 mmHg vs 5 
mmHg; p=0.019) were demonstrated.  
 
 
Table 2. Hemodynamic characteristics on cardiac catheterization of overall 
sample and according to results of Late Gadolinium Enhancement. 
 
Overall sample 
n = 127 
Junctional LGE 
present 
n = 48 
Junctional LGE 
absent 
n = 79 
p 
  PAMP > 25 mmHg 58 (46) 28 (58) 30 (38) 0.026 
  PCWP > 15 mmHg 67 (53) 34 (71) 33 (42) 0.001 
  LVEDP > 12 mmHg 88 (69) 42 (88) 46 (58) 0.001 
  CI (L/min/m2) 2.6 (2.0-3.1) 2.5 (1.9-2.8) 2.6 (2.2-3.1) 0.460 
  PVR (Wood) 1.6 (1.1-2.5) 1.6 (1.1-2.5) 1.5 (1.5-2.1) 0.257 
  RAP (mmHg) 5 (3-8) 6 (4-10) 5 (2-8) 0.019 
LGE= Late Gadolinium Enhancement; PAMP= Pulmonary Artery Mean Pressure; PCWP = 
Pulmonary Capillary Wedge Pressure; LVEDP = Left Ventricular End-Diastolic Pressure; CI = 
Cardiac Index; PVR = Pulmonary Vascular Resistance; RAP = Right Atrial Pressure.  
Categorical variables are presented as number of patients (%). Continuous values are 
expressed as median with 25% and 75%-iles. 
 
 
Among clinical and functional parameters both the value of RV and LV EF 
were significant in predicting junctional LGE (table 3), but only the RV EF resulted 
the independent one.  
All right catheterization parameters indicating a worse hemodynamic status 
were significant on univariate analysis (table 3). The best variable at univariate 
analysis resulting with a higher HR in predicting junctional LGE was LVEDP.    
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In the final multivariate model RV EF and LVEDP resulted independent 
predictor of junctional LGE (LVEDP:  OR 3.798; 95% CI 1.405-10.265, P= 0.009 and  
RV EF: OR 0.937; 95% CI 0.896-0.981, P=0.005). 
 
 
 
 
Table 3. Clinical, functional and hemodynamic predictors of junctional LGE. 
 
Univariate analysis Multivariable analysis* 
OR CI p OR CI p 
Age (years) 1.009 0.986-1.033 0.441    
NYHA I-II 0.928 0.637-1.354 0.700    
LBBB 0.963 0.451-2.057 0.922    
LV EF (%) 0.956 0.918-0.995 0.027    
LV EDV (mL/m2) 1.005 0.995-1.015 0.313    
RV EF (%) 0.925 0.885-0.967 0.001 0.937 0.896-0.981 0.005 
RV EDV (mL/m2) 1.015 0.995-1.036 0.140    
       
PAMP > 25 mmHg 2.287 1.100-4.754 0.027    
PCWP > 15 mmHg 3.385 1.537-7.285 0.002    
LVEDP > 12 mmHg 5.022 1.913-13.184 0.001 3.798 1.405-10.265 0.009 
Abbreviations as in Table 1 and 2.  
* final model. 
 
 
 
Representative cases of a patient with post-capillary pulmonary 
hypertension and junctional LGE compared with a patient without pulmonary 
hypertension and no LGE is shown on Figure 3.  
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Figure 3. Hemodynamics data provided by right heart catheterization in patients with and 
without pulmonary hypertension and the corresponding post contrast CMR findings (short axis 
view).  On the top a patient with post capillary pulmonary hypertension presenting a LGE area 
in the inferior ventricular junction (white arrow head). On the bottom, patient with normal 
pulmonary pressure values without LGE on post contrast CMR image. Abbreviations in the text.  
 
 
 
PAMP 
PAMP 
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Survival analysis 
During a 24 months follow-up, 15 patients (12%) had death/heart 
transplantation/ventricular assist device, 7/48 (15%) in the junctional LGE group 
versus 8/79 (10%); 18 subjects (14%) had at least an episode of HF requiring 
intravenous administration of diuretics and inotropes, 14/48 (29%) among 
junctional LGE group versus 4/79 (5%). Ten patients (8%)  experienced ventricular 
arrhythmias or sudden cardiac death, 4/48 (8%) in the junctional LGE group 
versus 6/79 (8%). Figure 4 shows Kaplan-Meier analysis of survival from heart 
failure end point (A and B), arrhythmic end point (C and D) and death/heart 
transplantation end point (E and F), each stratified both by the presence of 
junctional LGE and by non junctional LGE. Regarding HF end point both junctional 
LGE and non junctional LGE are associated with a worse follow up but only 
junctional type reaches the statistical significance. Regarding arrhythmic end 
point, only non junctional type seems to be a predictor of events.    
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Figure 4. Kaplan-Meier analysis of survival from different endpoints. See text.  
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Autopsy data 
During follow-up, 2 patients with junctional LGE previously demonstrated in 
vivo by CMR underwent heart transplantation. Comparison of the macroscopic 
appearance of the cut surface of the heart suggested fibrosis and interstitial 
expansion particularly affecting the right ventricular insertion points (Figure 5).  
There was excellent agreement between the pathological location of junctional 
expansion and the pre-mortem location of LGE on right ventricular insertion 
points with LV, so called “junctions”. 
 
 
Figure 5. Representative histology of the RV-LV insertion point showing expansion of the 
interstitium and myocardial fibers with different orientation. 
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Cardiac Magnetic Resonance predictors of events 
During a 24 months follow up both LV EF (HR 0.943; 95%CI 0.890-0.999; p= 
0.044) and RV EF (HR 0.939; 95%CI 0.899-0.981; p= 0.005) were predictor of HF 
events during 24 months follow up. Also the presence of LGE (overall) seems to 
predict the occurrence of HF, as well the presence of junctional LGE (HR 6.566; 
95% CI 2.16-19.955; p=0.001). Of note, dividing population by the presence of the 
classical LGE pattern (i.e. stria, without considering junctional involvement), the 
LGE fails to predict HF events (Table 5).  
For the arrhythmic end point, only RV dysfunction (HR 0.925; 95% CI 0.872-
0.980; p=0.008) and the presence of a non junctional LGE pattern (HR 5.102; 95% 
CI 1.081-23.809; p=0.040) were predictors of events (Table 6), instead 
junctional LGE fails.  
Finally, regarding death/heart transplantation neither the presence of LGE 
or any pattern of LGE were able to predict events, but only RV and LV dysfunction 
(Table 7).   
 
 
Table 5. CMR  predictors of heart failure. 
 
Univariate analysis 
HR CI p 
LV EF (%) 0.943 0.890-0.999 0.044 
LV EDV (mL/m2) 1.005 0.993-1.018 0.415 
RV EF (%) 0.939 0.899-0.981 0.005 
RV EDV (mL/m2) 1.031 1.007-1.055 0.011 
LGE overall 6.113 1.405-26.589 0.016 
Junctional LGE 6.566 2.160-19.955 0.001 
Non junctional LGE 2.457 0.923-6.546 0.072 
Abbreviations as in Table 1 and 2.  
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Table 6. CMR predictors of arrhythmias/sudden cardiac death. 
 
Univariate analysis 
HR CI p 
LV EF (%) 1.011 0.951-1.074 0.728 
LV EDV (mL/m2) 1.012 0.995-1.028 0.162 
RV EF (%) 0.925 0.872-0.980 0.008 
RV EDV (mL/m2) 1.027 0.995-1.060 0.105 
LGE overall 6.733 0.853-53.145 0.070 
Junctional LGE 1.129 0.318-4.000 0.852 
No junctional LGE 5.102 1.081-23.809 0.040 
Abbreviations as in Table 1 and 2.  
 
 
Table 7. CMR predictors of death/heart transplantation/assist device. 
 
Univariate analysis 
HR CI p 
LV EF (%) 0.900 0.836-0.969 0.005 
LV EDV (mL/m2) 1.011 0.997-1.024 0.131 
RV EF (%) 0.934 0.899-0.980 0.006 
RV EDV (mL/m2) 1.026 1.000-1.054 0.052 
LGE overall 1.090 0.388-3.062 0.870 
Junctional LGE 0.665 0.241-1.835 0.431 
No junctional LGE 1.005 0.358-2.822 0.993 
Abbreviations as in Table 1 and 2. 
 
 
We preferred no to do multivariable analysis because of the small number 
of events during follow up. 
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3.5 Discussion and conclusions 
 
In this study we demonstrated that the presence of so-called “junctional 
LGE” in the right ventricular insertion points is a frequent CMR finding in DCM, up 
to 38% in our population. The strict relationship between all hemodynamic 
parameters indicating the presence of PH complicating the DCM with junctional 
LGE makes this peculiar CMR pattern not specific for pre-capillary PH as herein 
demonstrated, but related to all conditions of RV overload. The junctional LGE 
pattern on follow-up was able in our study to identify the patients at risk for 
developing heart failure in a short term follow up. Hence, since its relationship 
with PH, it might assume the role of an imaging marker of patients more likely to 
worsen clinically in terms of decompensated HF. The prognostic value of classical 
LE pattern (i.e. midwall stria) appears to be less specific in predicting HF 
hospitalization nevertheless is confirmed the strongest predictor of arrhythmias. 
 
Junctional LGE and hemodynamics in dilated cardiomyopathy 
The LGE in the right ventricular insertion points with interventricular 
septum has been described up to 65% of patients with pulmonary arterial 
hypertension (PAH) in whom chronic RV pressure overload may increase 
interventricular wall stress (26), independently from the underlying etiology. 
Contrast LGE of the septal right ventricular insertion points has also been 
reported in congenital heart disease with RV overload (33, 34). In transposition of 
great arteries, in which RV pressures may be similar to those in severe PAH, the 
extent of hyperenhancement also correlates inversely with RV ejection fraction 
(33). Recently a similar LGE junctional pattern has been recognized in endurance 
athletes up to 13% of subjects (37). The considerable increases in pulmonary 
pressures demonstrated in trained athletes during intense exercise suggest a 
similar physiological stress, albeit only transient (37). All these clinical conditions 
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are characterized by chronic or transient increased pulmonary pressure reflecting 
in a RV remodeling. However, PH is a heterogeneous entity with different causes 
leading to increased pressures in the pulmonary circulation. In fact, a combination 
of elevated LV filling pressures, reactive pulmonary arterial vasoconstriction, and 
pulmonary vascular remodeling results in PH secondary to left heart disease (45). 
A typical disease in which PH resembles this pathophysiological model is DCM. 
Among CMR studies evaluating the LGE pattern in DCM, a junctional contrast 
deposition has been describe since initial experience (35) through more recent 
paper (36). However, no relationship with hemodynamic parameters, in particular 
PH, has been investigated.  
The novelty of our study is the comparison between right heart 
catheterization measures and CMR findings aimed to evaluate a possible 
explanation of junctional LGE in this specific patient population. In our study we 
demonstrated that the presence of so-called “junctional LGE” in the RV insertion 
points with septum, alone or associate with mid-septal stria, is not a rare CMR 
findings in DCM, up to 38% in our population. Moreover the percentage of 
subjects showing this peculiar pattern increased with the values of mean 
pulmonary artery pressure and wedge pressure. This observation confirms 
previous studies in which junctional LGE was associated with PH, but extent this 
association also in those with post-capillary PH as DCM. In the setting of DCM, has 
been recognized that increased LV filling pressures (measured by LVEDP), lead to 
pulmonary venous hypertension and post-capillary PH: when the elevation in 
venous pressure is chronic, excessive and persistent, it triggers a multistep 
adaptive process that involves not only the pulmonary vasculature, but also the 
RV remodeling. Under normal conditions, the RV operates against a low-
impedance, high-capacitance, low-pressure system, with a short isovolumetric 
contraction period and a prolonged systolic ejection time (46). Although the RV is 
well suited to accommodate an increased in volume overload, it is exquisitely 
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afterload sensitive. Moreover, the RV and LV are connected in series and the 
impaired LV filling influences also the RV function as a cross talk or coupling 
between the right and left sides, referred to as diastolic ventricular interaction 
(46, 47). Left ventricle filling pressure directly measured by LVEDP and indirectly 
by PCWP, represents the downstream load imposed by the left heart on the RV. 
All these mechanisms are the basis of LV and RV remodeling due to PH, in 
particular in the DCM patients. Looking to right ventricular insertion points has 
been recognized that are regions of a particular mechanical stress as 
demonstrated by experimental studies that identified these regions, and later the 
interventricular septum, as the earliest sites of immune-reactive-atrial natriuretic 
peptide expression (48).  
 
Anatomical basis of junctional LGE 
In a normal heart, cardiac myofiber orientation plays a role in the uniform 
transmural distribution of mechanical stress and strain (49). The septum is a 
midline structure between the two ventricles and is composed of oblique fibers 
from two layers of the myocardial band able to provide the characteristic motion 
of “twisting” of the septum, with most dense cross at the level of insertion LV and 
RV regions. The RV insertion points with interventricular septum are regions of 
particular mechanical stress, even under normal physiological conditions. As 
demonstrated by previous histological studies, in the small area of junctions 
between the ventricular septum and RV free wall, myocite disarray and fibrosis 
were not so rare in control hearts (50). All conditions able to disrupt normal 
architecture by stretching the septum so that a more transverse, rather than 
oblique fiber orientation comprises its spatial configuration (51); as a 
consequence the alteration of myoarchitecture mostly in more “stressed” points 
in combination with alterations in the connective tissue matrix provide the 
structural basis for slow washout kinetics of gadolinium in diseased tissue. 
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Delayed contrast enhancement has been initially well characterized in relation to 
ischemic heart disease (52), in which the LGE represents the post-infarction scar. 
However, as experimentally demonstrated, the main mechanism of gadolinium 
deposition is the expansion of extracellular space such as myocites disruption, 
inflammation, increase in fat and fibrosis (as replacement type or interstitial). 
Moreover, previous clinic-pathological studies demonstrated that LGE in the 
setting of hypertrophic cardiomyopathy correlates not only with fibrosis and 
myocardial collagen, but also myocite disarray (32). So far, the histological basis 
of LGE in PAH have been proven only in a case report in which microscopy 
showed myocardial disarray, increased collagen and fat between fiber bundles 
without signs of replacement type of fibrosis (30). In another case, without CMR 
comparison, the specimen from interventricular septum of a woman affected by 
PAH showed extracellular expansion and edema with fibrosis (29). 
In the setting of DCM, Assomul (41) provided a good correlation between 
circumferential LGE on pre-mortem CMR and fibrosis detected on autopsy, 
without a specific overview on junction section. In our study we provided the 
histological basis of LGE deposition in a patient with DCM complicated by reactive 
PH who underwent heart transplantation (Figure 5). Even in this case, as 
demonstrated in normal controls (50), the typical histological features previous 
seen in the right ventricular insertion points with interventricular such as disarray, 
fat, not pathologic fibrosis, and microvessels are expanded in this patient, 
probably due to mechanical stress, with edema: all conditions able to increase the 
distribution volume of gadolinium. Moreover, the at the junction site even in 
transplanted patient the traditional fibrosis findings are lacking, compared to 
lateral wall where the typical replacement type fibrosis also lead to LGE 
deposition. 
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In this study we demonstrated for the first time in the setting of DCM that 
junctional LGE reflects all hemodynamic adaptation of RV in this disease, as 
demonstrated by the strong association with WP and LVEDP. 
 
Clinical significance of junctional remodeling in dilated cardiomyopathy 
Increased mortality and hospitalization rates have been reported in HF 
patients with echocardiographycally estimated PH (22), and PAMP is an 
independent predictor of the need for cardiac transplantation (24) and the 
following outcome (46). On this basis, the final adaptive capability of the RV to 
the severity of pulmonary vascular disease seems a fundamental prognostic 
factor, regardless of LVEF and stage of HF. In our study we demonstrated that 
patients showing junctional LGE had a worse clinical outcome in terms of HF in a 2 
years follow up. The prognostic significance of LGE has been recently 
demonstrated in the setting of DCM, in which its presence is related to worse 
clinical outcome, mostly as arrhythmic events. However, no specific association 
between typical LGE pattern and outcome has been demonstrated (42). In our 
population patients with junctional LGE had more episodes of HF compared with 
those with other pattern non including LGE at the level of the RV insertion points 
with septum; on the other hand, DCM with LGE, but not junctional, showed more 
arrhythmic events and all SCD occurred in this group. Thus, this observation 
confirm the role of LGE as predictor of outcome in DCM, but suggests that the 
role of junctional LGE in the arrhythmogenesis is limited, improving its 
significance in the detection of subject at risk of HF even treated with optimized 
medical treatment.  
The identification in vivo of possible mechanism responsible for hypothetic 
reversible junctional LGE deposition may be useful to identify patients at risk for 
developing HF. In this context, the visualization of junction edema, leading later 
to contrast extravascular deposition, may be obtained using T2-weighted imaging, 
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so far not included in the CMR protocol of DCM study. Adding these information 
and future application on T1 and T2 mapping may provide further information. 
 
Conclusions 
Our study evaluated the features of so-called “junctional LGE” in the right 
ventricular insertion points. This is a frequent CMR findings in DCM, and it is 
related to all hemodynamic parameters indicating the presence of PH 
complicating the DCM, including RV systolic dysfunction, due to left side and so 
resulting not specific for pre-capillary PH. 
Patients with junctional LGE are significantly more likely to worsen clinically 
in terms of decompensated HF, meaning that this peculiar CMR pattern may be a 
marker of incipient RV global impairment, instead doesn’t represent a flag of 
arrhythmic risk.  
 
Limitations 
Further studies on larger populations, able to provide new insight in the 
comprehension of mechanism involved in the junctional LGE development in vivo, 
may be useful to confirm these data and, thereafter, monitor the efficacy of 
therapies. 
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Chapter 4 
 
CLINICALLY SUSPECTED ACUTE MYOCARDITIS 
The prognostic and expounder role of edema as detected by 
CMR  
 
4.1 Introduction 
 
Acute myocarditis is an inflammatory disease of the heart muscle most 
often caused by infectious agents such as viruses or autoimmune conditions. The 
majority of affected patients have a mild and transient cardiac involvement and 
favorable clinical outcome with complete clinical recovery; heart failure and 
arrhythmic sudden death are less common clinical presentations (53,54). The 12-
lead electrocardiogram (ECG) is usually abnormal in myocarditis, although 
changes are neither sensitive nor specific. Most frequent ECG abnormalities in 
acute myocarditis consist of ST-segment displacement and negative T-waves, 
which may mimic those seen in acute coronary syndromes. The prevalence of T-
waves inversion (TWI) ranges from 9 to 48% (54-61). The pathophysiologic 
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mechanisms and the prognostic meaning of TWI occurring in acute myocarditis 
remain to be elucidated. Cardiac magnetic resonance has become the gold 
standard imaging technique for tissue characterization and identification of 
myocardial lesions such as edema and fibrosis, which may represent the substrate 
for electrical disturbances leading to ECG changes in acute myocarditis (43). 
Previous CMR studies (which lacked T2-weighted sequences for myocardial 
edema) found that development of TWI in patients with acute myocarditis 
correlated with the extent of LV myocardial LGE (55,59). We previously 
demonstrated a pathophysiologic link between dynamic TWI and transient 
myocardial edema in Tako-tsubo cardiomyopathy, a condition which shows many 
similarities with acute myocarditis such as clinical presentation with chest pain, 
ST-segment elevation, TWI, myocardial enzymatic release and reversible 
ventricular dysfunction (62-65). Unlike Tako-tsubo cardiomyopathy, TWI is not 
observed in all patients with acute myocarditis: this provides an ideal study model 
to further test clinically the pathophysiologic link between myocardial edema 
(amount, regional distribution and transmural arrangement) and occurrence of 
TWI. Since Tako-tsubo cardiomyopathy, after passing acute phase, has a benign 
prognosis, we suggest that acute myocarditis presenting with TWI may represent 
a transient inflammation with a preponderant myocardial edema rather than 
myocardial fibrosis, as in tako-tsubo, and so a benign prognosis.   
 
4.2 Aims  
Our aims are to evaluate the relationship between TWI and myocardial 
edema as evidenced by CMR in a series of consecutive patients admitted for 
clinically suspected acute myocarditis. In addition, we investigated whether TWI 
during the acute/subacute disease phase predicted LV  dysfunction during follow-
up. 
41 
 
4.3 Methods 
 
Study population  
The study enrolled consecutive patients acutely admitted to our 
department between January 2012 and December 2014 for clinically suspected 
acute myocarditis (53) based on: 1) consistent clinical symptoms; 2) elevated 
Troponin I levels and 3) CMR imaging evidence of both regional increase of 
myocardial signal intensity in T2-weighted edema images and ≥1 local lesion in 
post-contrast inversion recovery T1-weighted images (late gadolinium 
enhancement, LGE) with non-ischemic regional distribution (43). Coronary artery 
disease was ruled out by coronary angiography or by stress-induced myocardial 
ischemia test in all patients. According to the American Heart 
Association/American College of Cardiology Foundation/European Society of 
Cardiology scientific guidelines on the role of EMB in cardiovascular diseases (66)  
confirmatory endomyocardial biopsy was reserved to the 8 patients presenting 
with heart failure symptoms and/or moderate to severe LV dysfunction. Six 
months after discharge, patients underwent a follow-up clinical evaluation 
including ECG and echocardiography. A CMR follow up scan was limited to the 
subgroup of patients showing LV dysfunction at 6-months follow up. Patients with 
rhythm and conduction disturbances such as atrial fibrillation, complete bundle 
branch block and atrioventricular block, as well as those with standard 
contraindications to CMR were excluded from the study. Each patient gave 
written informed consent to participate in the study. 
 
Study protocol 
A standard 12-lead ECG was recorded at the time of CMR, at a paper speed 
of 25 mm/s and an amplification of 10 mm/mV. Electrocardiographic data were 
evaluated by an observer who was unaware of clinical data and CMR results. 
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Standard measurements included heart rate; rhythm; PR interval; QRS axis, 
voltage, and duration; ST-segment and T-wave abnormalities. TWI was defined as 
the presence of negative T-waves of amplitude ≥1 mm in at least two contiguous 
ECG leads. The following locations of TWI across the 12 ECG leads were 
considered: 1) “anterolateral” for TWI in leads V1 through V4 extending to leads 
V5-V6, to leads I, aVL or both leads; 2) “inferolateral” for TWI in leads II, III, aVF 
extending to V5, V6; and 3) “diffuse” for TWI in both anterolateral and 
inferolateral leads. . In the subset of 13 patients who underwent a second CMR 
study during follow-up, we compared the sum of QRS voltages in limb leads, 
precordial leads and aVR lead of ECG recordings obtained at the time of acute and 
follow-up CMR studies. 
 
CMR  protocol and analysis 
Cardiac magnetic resonance was performed on a 1.5-Tesla scanner 
(Magnetom Avanto, Siemens Medical Solutions, Germany) within 8 days from 
symptoms onset. All patients underwent a comprehensive CMR study protocol 
including cinetic, edema, early and delayed post-contrast sequences (1,5,43,64). 
See the Appendix for CMR acquisition details. The images of CMR were evaluated 
and analyzed independently by 2 observers, blinded to ECG and clinical findings, 
with the use of dedicated software (CMR42, Circle Cardiovascular Imaging Inc). In 
case of disagreement a third observer was consulted. Global ventricular volumes, 
systolic function and LV myocardial mass were calculated from the short-axis cine 
images, excluding papillary muscles from the myocardium. A 6 equiangular 
segmental approach for each short axis slice was used, finally resumed in the 
American Heart Association 17-segments-model. Slices with artifacts were not 
considered for edema assessment. The presence of myocardial edema on T2-
weighted images was diagnosed using a dark blood sequence to reduce artifacts 
and, moreover, “slow flow artifacts” were excluded comparing T2-weighted 
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images with cine images side by side on the same cardiac phase. Myocardial 
edema was identified and quantified by semi quantitative analysis according to 
the workflow published in the Society for Cardiovascular Magnetic Resonance 
position statement (1) and all edematous regions were confirmed in two 
perpendicular views. Semi quantitative analysis was performed using regional T2-
ratio method and the presence of myocardial edema was diagnosed when signal 
intensity (SI) was 2 or higher compared with that of the skeletal muscle.  
Myocardial edema was defined as “transmural” when it extended from the 
epicardium to the endocardium by more than 75% of the LV thickness in ≥2 
adjacent segments. Early Gadolinium Enhancement was defined as global SI 
enhancement ratio of myocardium over skeletal muscle ≥ 4.0 or absolute value of 
myocardial SI enhancement ≥45% than pre-contrast myocardial SI. Myocardial 
LGE was assessed with an automated thresholding and considered present if SI 
was > 3 standard deviations above remote myocardium. Location of TWI across 
the 12 ECG leads and regional distribution of myocardial edema on CMR were 
considered concordant in the presence of: 1) TWI in the antero-lateral leads and 
myocardial edema localized in the anterior septum, anterior wall and/or antero-
lateral wall, 2) TWI in the infero-lateral leads and myocardial edema localized 
(>75% of edematous LV segments) in the inferior septum, inferior wall and/or 
infero-lateral wall, 3) diffuse TWI (both anterolateral and infero-lateral leads) and 
diffuse myocardial edema (involving both the anterior septum, anterior wall 
and/or antero-lateral wall and inferior septum, inferior wall and/or infero-lateral 
wall).   
 
Statistical analysis  
Continuous variables were reported as median (25°-75° percentiles) and 
compared using the rank sum test because of the small size of subgroups. 
Categorical variables were analyzed with the chi-squared test or the Fisher’s exact 
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test, as appropriate. Comparison between continuous variables was performed 
with the Mann-Whitney U test for unpaired samples and with the Wilcoxon 
signed rank test for paired samples. The presence of transmural edema, the 
number of segments with edema and the number of segment with LGE were 
entered into a multivariable binary logistic regression model for prediction of 
TWI. Concordance between localization of TWI and regional distribution of 
myocardial edema was evaluated by the Cohen kappa statistic test. The inter-
observer agreement was evaluated by the Cohen kappa statistic test. A 2-tailed 
p<0.05 was considered statistically significant. All analyses were performed using 
SPSS 17 (SPSS Inc; Chicago, IL). 
 
 
4.4  Results 
 
Clinical and electrocardiographic findings 
The patient population included 76 patients (87% male, median age 34 
years). The baseline clinical characteristics of the study population are 
summarized in Table 8. Chest pain was the most common reason for seeking 
medical attention (N=67, 88%), dyspnea was the onset symptom in 3 subjects 
(4%), palpitation in 6 (8%). Coronary artery disease (i.e., coronary stenosis <50%) 
was excluded by coronary angiography in 56 (74%) patients. The remaining 20 
(26%) patients did not undergo coronary angiography as they were considered as 
having a low pretest probability of coronary artery disease, because of young age, 
absence of coronary risk factors, and obvious recent gastrointestinal or 
respiratory infection; in these patients the absence of stress-induced myocardial 
ischemia was demonstrated by exercise testing and/or single-photon emission 
computed tomography. All patients had elevated troponin I levels with a median 
45 
 
peak of 9.9 ug/L. The echocardiography showed reduction of LV ejection fraction 
in 29 (38%) patients with a median value of 48% (43-51); a LV ejection fraction 
<45% was documented in 8 (11%) patients. A mild pericardial effusion was 
detected in 13 (17%) patients.  
Table 9 summarizes ECG findings at the time of CMR. All patients were in 
sinus rhythm. None had a bundle branch block (median QRS duration 90 msec). 
Two patients (3%) had low amplitude (<0.5mV) of QRS complex in limb leads. TWI 
was observed in 21 (27%) patients. In the subset of 13 patients who underwent a 
second CMR study during follow-up, there was a trend towards a lower amplitude 
of QRS complexes on the acute ECG compared with follow-up ECG obtained at the 
time of CMR studies but, probably due to the small number, this was not 
statistically significant: from 61 mV (46-73) to 63 mV (44-73) in limb leads 
(p=0.34), from 86 mV (79-97) to 87 mV (78-98) in precordial leads (p=0.09), and 
from 10 mV (8-11) to 11 mV (8-12) in aVR lead (p=0.257). 
 
Table 8. Clinical characteristics of population 
Data are presented as median (1st-3rd quartiles) or N(%). 
EDV= end-diastolic volume, EF=ejection fraction, LV=left ventricle, TWI=T-waves inversion. 
 
Overall  
(n=76) 
No TWI 
(n=55) 
TWI 
(n=21) 
p 
Male 66 (87) 49 (89) 17 (81) 0.45 
Age, (years) 34 (26-43) 34 (24-42) 37 (26-49) 0.93 
Recent flu 48 (63) 36 (66) 12 (57) 0.60 
Clinical presentation     
Chest pain 67 (88) 51 (93) 16 (76) 0.11 
Dyspnea 3 (4) 1 (1.8) 2 (9.5) 0.18 
Palpitations 6 (8) 3 (6) 3 (14) 0.34 
Laboratory data     
Peak Troponin I, ug/L 9.9 (4.4-20.2) 10 (4-20.2) 8.2 (6-23) 0.85 
Peak C-Reactive Protein, mg/dL 26 (3.6-56) 30 (7.2-68) 20 (3.1-38) 0.16 
Echocardiogram     
LV EDV, ml/m2 59 (52-67) 59 (54-67) 50 (46-62) 0.02 
LV EF, % 57 (51-63) 58 (51-63) 56 (49-61) 0.86 
Pericardial effusion,  13 (17) 10 (18) 3 (14) 1.0 
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Table 9. Electrocardiographic features at time of CMR 
#Low QRS amplitude if QRS mean voltage < 5mV in limb leads. 
 
 
 
 
Cardiac Magnetic Resonance findings 
The median interval between symptom onset and CMR was 5 (3-7) days. 
CMR findings are shown in Table 10. All patients had ≥ 1 LV myocardial segments 
showing myocardial edema on T2-weighted sequence and ≥ 1 LV myocardial 
segments showing non ischemic LGE on post-contrast sequences which fulfilled 
Lake Louise criteria for myocarditis (Table 3). The median number of LV segments 
showing any pattern of myocardial edema (transmural and non-transmural) was 3 
(2-5). Thirty patients (39%) had ≥2 LV segments showing myocardial edema with a 
transmural pattern. We found an increased global myocardial early gadolinium 
enhancement ratio in 46 of 76 patients (61%). The median number of LV 
segments with LGE was 3 (2-5). The morphology of LGE was “stria” type in 41 
(54%) patients and “patchy” type in 35 (46%).  
 
 
ECG features 
Median (1st-3rd quartiles)  
or Number of patients (%) 
Sinus Rhythm 
PR interval, median msec 
QRS duration, median msec 
QRS axis, median degrees 
QRS Low amplitude# 
76 (100) 
150 (145-170) 
90 (90-100) 
50 (40-60) 
2 (3) 
ST elevation 25 (33) 
ST depression 0 
Negative T-waves 
    Antero-lateral 
    Infero-lateral 
    Diffuse 
21 (28) 
10 (13) 
9 (12) 
2 (3) 
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Relationship between clinical, ECG and CMR features.  
Baseline clinical characteristics and CMR features according with the 
presence of TWI are reported in Table 8 and 10. Patients with and without TWI 
did not differ with regards to LV ejection fraction, LV volume, LV mass and 
Troponin I peak values. At CMR, the number of LV segments with any pattern of 
myocardial edema (transmural and non-transmural), the number of LV segments 
with a transmural pattern of myocardial edema and the number of LV segments 
with LGE were higher in patients with TWI than in those without TWI. About early 
enhancement, its prevalence did not differ significantly among patients with and 
without TWI. Transmural edema of ≥2 LV segments was present in 17/21 (81%) 
patients with TWI versus 13/55 (24%) patients with no TWI (p<0.001). There was 
no association between repolarization abnormalities and specific LGE patterns 
(“stria” versus “patchy”). At multivariable analysis (Table 11) the presence of 
transmural myocardial edema of ≥2 LV segments remained the only independent 
predictor of TWI at the time of CMR. 
Regional correlation analysis demonstrated that 6/10 (60%) patients with 
antero-lateral TWI showed myocardial edema confined to the antero-
septal/anterior/antero-lateral LV segments, while 4/9 (44%) patients with infero-
lateral TWI showed myocardial edema confined to the infero-
septal/inferior/inferior-lateral LV segments; the other 2 patients with diffuse TWI 
showed myocardial edema in both LV regions. The overall concordance between 
TWI and myocardial edema (either transmural or non-transmural) was observed 
in 12 (57%; k=0.42) patients, while the other 9 (43%) patients had myocardial 
edema extending beyond LV segments explored by leads exhibiting TWI. A sub-
analysis of topographic agreement among patients with TWI and a transmural 
pattern of myocardial edema showed a 100% concordance (8/8) in patients 
presenting with antero-lateral TWI and a 71% concordance (5/7) in patients with 
infero-lateral TWI; the 2 patients with diffuse TWI showed transmural myocardial 
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edema in both LV regions. Overall, the topographic agreement between TWI and 
a transmural pattern of myocardial edema was 88% (15/17; k=0.81). The two 
“discordant” patients had infero-lateral TWI and transmural myocardial edema 
both in the infero-lateral and the antero-lateral wall. Figure 6-7-8 show the 
electrocardiograms and the CMR findings in three patients. 
 
Interobserver agreement on the presence of transmural edema was 95% 
(72/76, kappa=0.88). Interobserver agreement was 94% (16/17, kappa=0.88) for 
the presence of transmural myocardial edema in the anterior segments and 88% 
(15/17, kappa=0.77) for the presence of transmural myocardial edema in the 
inferior segments. 
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Table 10. CMR finding according to the presence of T-waves negative. 
 
Overall 
(n=76) 
No TWI 
(n=55) 
TWI 
(n=21) 
P 
Functional CMR     
LV EF, (%) 60 (55-64) 60 (55-64) 60 (54-60) 0,293 
LV EDV, ml/m2 61 (54-70) 65 (56-70) 55 (50-64) 0.056 
LV mass, g/m2 59 (55-65) 58 (55-63) 61 (55-66) 0.345 
Number of patients with regional kinetic 
abnormalities 
28 (37) 9 (43) 19 (90) 0.597 
T2-w sequence analysis     
Median number of LV segments with any edema 
per patient 
3 (2-5) 3 (2-4) 5 (3-7) 0.015 
Number of patients with transmural myocardium 
edema in ≥2 LV segments 
30 (39) 13 (24) 17 (81) 0.000 
Median number of LV segments with transmural 
edema per patient 
0 (0-3) 0 (0-1) 2 (2-3) 0.000 
Early enhancement analysis 
Number of patients with increased EGE ratio 
 
46 (61) 
 
30 (55) 
 
16 (76) 
 
0.080 
Late enhancement analysis     
Median number of LV segments with LGE per 
patient 
3 (2-5) 3 (2-4) 4 (3-7) 0.002 
Data are presented as median (25°-75° %iles) or N(%).  
LGE=late gadolinium enhancement. Abbreviations: see table 1 
 
 
 
Table 11. Multivariable analysis for predictors of T-waves inversion 
 OR 95% CI p 
LV segments with any edema 1.05 0.77-1.43 0.752 
Presence of transmural edema in ≥2 LV segments  9.96 2.71-36.6 0.001 
LV segments with LGE 1.21 0.89-1.65 0.215 
Abbreviations: see table 1-3 
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Figure 6 - Representative patient with no T-wave inversion. ECG at the time of CMR showing 
the absence of TWI (A). Long-axis 3-chamber view showing infero-lateral myocardial edema in 
T2-weighted sequences (B). Semiquantitive analysis by CMR42, showing the non-transmural 
arrangement of myocardial edema which is confined to the epicardial layer. The blue area 
depicts myocardial T2 intensity signal >2.0 compared with the skeletal muscle (C). 
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Figure 7 - CMR findings in a representative patient with inferior TWI. ECG at the time of CMR 
showing the presence of negative T waves in inferior leads (A). Long-axis three-chamber view 
showing infero-lateral myocardial edema in T2-weighted sequences (B). Semiquantitive analysis 
by CMR42, Circle Cardiovascular Imaging Inc. software showing the transmural arrangement of 
myocardial edema (C). 
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Figure 8 - CMR findings in a representative patient with anterior TWI. ECG at the time of CMR 
showing negative T waves in anterior leads (A). Two-chamber view showing anterior myocardial 
edema in T2-weighted sequences (B). Semiquantitive analysis by CMR42, Circle Cardiovascular 
Imaging Inc. software showing the transmural arrangement of myocardial edema (C). 
 
 
Follow-up data 
Follow-up data were available for 68 of 76 patients (18 of 21 patients with 
TWI and 50 of 55 without TWI). At a 6-month control ECG all patients exhibited 
normalization of T-waves polarity. Thirteen (19%) had reduced LV EF (<55%) on 
echocardiographic examination. At this time, a follow-up CMR study was 
performed in this subgroup of patients with echocardiographic LV dysfunction 
and demonstrated a complete normalization of SI value on T2-weighted 
sequences for myocardial edema, whereas a variable amount of non-transmural 
LV LGE was observed in all. Patients with a reduced LV EF at 6 months follow-up 
had during the acute phase significantly lower LV EF, higher LV end-diastolic 
volume and more severe LV wall motion abnormalities. At multivariable analysis 
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LV EF <55% at admission (OR=11.23; 95%CI=2.64-47.7; p=0.001) but no TWI 
(OR=1.61, 95%CI=0.33-7.77; p=0.555) predicted LV dysfunction at follow up (table 
12). 
 
Table 12 Clinical characteristics of population at admission according with the 
presence of left ventricular dysfunction at 6-month follow-up 
 EF > 55% 
(n=55) 
EF < 55% 
(n=13) 
P 
Male 46 (84) 12 (92) 0.67 
Age, (years) 34 (26-42) 40 (30-54) 0.17 
Recent flu 36 (66) 7 (54) 0.53 
Clinical presentation    
 Chest pain 49 (89) 10 (77) 0.36 
 Dyspnea 2 (4) 1 (8) 0.48 
 Palpitations 4 (7) 2 (15) 0.32 
Laboratory data    
 Peak Troponin I, ug/L 9.8 (4.4-16.5) 12 (6.6-49.8) 0.24 
 C-Reactive Protein, mg/dL 26 (4.1-38.1) 50 (3-94) 0.24 
Echocardiogram    
 LV EDV, ml/m2 56 (48-62) 62 (59-70) 0.02 
 LV EF, % 60 (55-64) 46 (43-52) <0.001 
 Pericardial effusion 9 (16) 3 (23) 0.69 
ECG (at the time of CMR)    
ST segment elevation 17 (31) 6 (42) 0.34 
ST segment depression 0 0 - 
Negative T-waves 15 (27) 3 (23) 1.0 
CMR     
 Cine sequences    
 LV EF, % 60 (52-66) 52 (50-55) <0.001 
 LV EDV, ml/m2 60 (52-66) 68 (60-73) 0.045 
 Number of patients with regional kinetic 
abnormalities 12 (22) 11 (85) <0.001 
 T2-w sequences    
Median number of  LV segments with edema per 
patient 3 (2-5) 4 (3-4) 0.16 
Median number of LV segments with      
transmural edema per patient 0 (0-2) 0 (0-2) 0.82 
 Post-contrast sequences    
 Median number of segments with LGE per 
patient 3 (2-5) 3 (2-7) 1.0 
Data are presented as median (25°-75° %iles) or n(%). 
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4.5 Discussion and conclusions 
This study was the first to characterize the myocardial tissue changes 
underlying TWI in patients with a diagnosis of clinically suspected acute 
myocarditis, who underwent a comprehensive CMR protocol including T2-
weighted and early/late gadolinium enhancement sequences. The major study 
suggestions, since the small number of subjects, were the following: 1) there was 
a significant association between quantitative parameters of LV myocardial 
edema as evidenced by T2-weighted sequences and TWI; 2) among the tissue 
characterization parameters, transmural extent of myocardial edema seems to be 
the only independent predictor of TWI suggesting that dispersion between 
epicardium and endocardium rather that the regional inhomogeneity of 
repolarization was the most involved electrophysiological mechanism; 3) there 
was an excellent topographic agreement between TWI location across the 12 ECG 
leads and regional distribution of transmural myocardial edema; 4) T-waves 
normalized in all patients and the presence of TWI during acute phase was not a 
unfavorable predictor of LV systolic dysfunction at 6-month period of follow-up.  
 
T-wave inversion and myocardial edema in acute myocarditis 
Our results confirm and extend previous CMR observations in patients with 
acute myocarditis by showing a significant association of TWI not only with the 
extent of LV LGE but also with quantitative parameters of LV myocardial edema as 
evidenced by T2- weighted sequences. However,  on multivariable analysis, only 
transmural myocardial edema remained an independent predictor of TWI on the 
ECG at the time of CMR. A likely explanation of this finding is that in most of our 
study patients,  LGE observed at the time of acute CMR evaluation could be a 
“reversible edema-related gadolinium myocardial enhancement”. In this regard, 
experimental studies showed that a delayed washout of gadolinium may be 
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caused not only by permanent myocardial necrosis/fibrosis but also by increased 
interstitial water content such that associated with reversible myocardial edema 
(67). The pathogenic link between edematous myocardium and repolarization 
abnormalities remains to be elucidated. One can speculate that the acute 
inflammatory process causes myocyte repolarization inhomogeneity, either 
regional (between regions affected and those spared by myocardial edema) or 
transmural (i.e. between endocardial and epicardial layers), which gives rise to 
inversion of T-waves polarity. The observation that transmural extent of 
myocardial edema was the most powerful predictor of TWI suggests that 
dispersion of action potential duration between epicardium and endocardium of 
the LV wall, rather than regional inhomogeneity of repolarization, was the most 
involved electrophysiological mechanism in our study patients. This finding is in 
agreement with previous studies on either ischemic or non-ischemic dynamic 
TWI, showing that transmural myocardial damage is a prerequisite for T waves to 
become negatives (62-63). Whether there is a direct cause-effect relationship 
between myocardial edema and action potential changes or these phenomena 
are two parallel effects of the inflammatory myocardial lesion remains to be 
addressed by future experimental and clinical studies. A transient attenuation of 
QRS voltages concomitantly with myocardial edema has been previously reported 
in patients with tako-tsubo cardiomyopathy (68). In the subset of our patients 
with acute myocarditis undergoing both acute and follow-up CMR studies, we 
observed a non statistically significant trend toward an attenuation  of QRS 
voltages on the acute ECG compared with follow-up ECG. The discrepancy may be 
explained by the lower number and patchy distribution of edematous LV 
segments in acute myocarditis compared with the homogeneous distribution and 
global involvement of mid-apical LV segments involved by myocardial edema in 
tako-tsubo cardiomyopathy. 
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LV segments with myocardial edema were not infrequently observed in LV 
regions different from those explored by the ECG leads showing TWI. Hence, the 
concordance between location of TWI on the ECG leads and the LV segments 
exhibiting any patterns of myocardial edema involvement was poor with an 
overall topographic agreement not exceeding 57%.  This finding is in keeping with 
the results of previous CMR studies (lacking T2- weighted sequences for 
myocardial edema) which showed a weak topographic between ECG leads 
showing ST-T abnormalities and location of myocardial damage assessed by LGE 
(55, 56, 59). In our study, the sub-analysis of topographic concordance between 
TWI and transmural myocardial edema showed an excellent overall agreement 
(88%). This reinforces the concept that occurrence of TWI mostly depends on the 
transmural extent of LV myocardial edema. 
 
Prognostic value of TWI 
Previous studies reported that development of TWI in acute myocarditis 
was significantly and independently associated to the extent of myocardial LV 
LGE. Thus, it was suggested that TWI could be used for a noninvasive estimation 
of the amount of myocardial damage, and, by inference, owing its ability to 
identify patients with larger areas of myocardial fibrosis, as a marker for risk 
stratification.  The present study demonstrated that the only independent 
predictor of echocardiographic reduction of LV ejection fraction at 6-month 
follow-up was LV dysfunction (EF < 55%) during the acute phase of the disease. Of 
interest, TWI was neither univariate nor multivariable predictor of a late 
impairment of LV systolic function. This finding provides further evidence that 
TWI reflects the underlying myocardial edema which is a completely (or almost 
completely) transient myocardial tissue change with no (or minimal) irreversible 
structural myocardial damage such as necrosis/fibrosis. In this regard, although 
we did not perform a control CMR study systematically, the analysis of the 
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subgroup of 13 patients undergoing CMR re-study at 6-month follow up because 
of a reduced LV EF, showed a complete resolution of myocardial edema in all, 
despite the presence of a variable amount of LV LGE.  
 
Conclusions and clinical implications 
Our study was the first to demonstrate a significant association between 
transmural myocardial edema as evidenced by CMR T2- weighted sequences and 
TWI in acute myocarditis. This finding obtained in patients with acute myocarditis 
provides further evidence that transmural myocardial edema is a common 
denominator which underlies both electrical and mechanical abnormalities of a 
series of conditions, either ischemic or non-ischemic, characterized by reversible 
ventricular dysfunction (stunned myocardium) and TWI. As an expression of 
reversible myocardial edema, TWI during acute phase of myocarditis does not 
represent a marker of unfavorable adverse prognosis because it underlies a 
transient impairment of myocardial function. The knowledge of this 
pathophysiologic link between repolarization abnormalities and transient 
myocardial edema may help to improve our diagnostic and prognostic assessment 
of patients presenting with “infarct-like” acute myocarditis. In this context, CMR 
may provide additional values 
 
Limitations 
The study population was relatively small because of the low disease 
prevalence and the limited number of affected patients with available and 
evaluable CMR study, including T2-weighted sequences. Although EMB is 
considered to be the “gold standard” for diagnosis of acute myocarditis, it was 
not performed in all our study patients but was reserved to patients presenting 
with symptoms of heart failure and/or moderate to severe LV dysfunction, 
according to international guidelines (66). Because most of our patients did not 
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have histological validation of diagnosis, we used thorough the manuscript the 
designation “clinically suspected acute myocarditis” which is the designation 
currently used to indicate a diagnosis of acute myocarditis based on clinical and 
CMR findings. 
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Chapter 5 
 
THE MITRAL VALVE PROLAPSE 
 
The arrhythmic landmark as evidenced by CMR 
 
5.1 Introduction 
  
Mitral valve prolapse (MVP) is characterized by typical fibro-myxomatous 
changes in the mitral leaflet tissue with superior displacement of one or both 
leaflets into the left atrium. Beside this general definition, the history of 
idiopathic MVP concealed a century of scientific debates, intuitions and pitfalls 
crossing all the last fifty years of Cardiology. 
Mitral valve prolapse is the most common valve disease with an estimated 
prevalence of 2-3% in the general population (69). Although MVP is generally 
regarded as a benign condition (70,71), the outcome is widely heterogeneous and 
complications such as mitral regurgitation, atrial fibrillation, congestive heart 
failure, endocarditis and stroke are well known. Ventricular arrhythmias and SCD 
have been even reported (72-90).  
From a pathologic anatomy point of view, accumulation of proteoglycans 
(myxomatous mitral valve) is the most common cause of MVP, accounting for 
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leaflet thickening and redundancy, interchordal hooding, chordal elongation and 
annular dilatation. While these valve abnormalities well explain mitral 
regurgitation and mechanical complications due to enhanced extensibility, the 
pathogenesis of ventricular arrhythmias/SCD in MVP remains unknown (82).  
Since the estimated rate of SCD in MVP ranges from 0.2% to 0.4% per year 
on the basis of prospective follow-up studies (69,72), one of the major clinical 
concerns with MVP is the incidence of ventricular arrhythmia and the occasional 
occurrence of SCD.  
 
Prevalence of arrhythmias in mitral valve prolapse 
Arrhythmias have long been recognized to occur in patients with MVP (80-82).  
The prevalence of premature atrial complexes was reported to range from 35% to 
63%, ventricular premature beats from 58% to 75%, and complex ventricular 
arrhythmias from 50% to 52% of MVP adult patients during prolonged 
ambulatory ECG recording.  However other authors (83), analyzing unselect out of 
hospital patients found only a modest trend toward more complex/frequent 
ventricular premature beats in MVP group respect the control group,  without 
reaching statistical significance. Of note, the definition of MVP to be enrolled was 
not the same across these studies, so the actual prevalence of complex 
arrhythmias in MVP depends on population-selection criteria.  
Rare cases of SCD have been associated with MVP since its early recognition 
(84-86) and it has become generally accepted that a small but important subset of 
patients with MVP has complex arrhythmias that are potentially lethal. Malignant 
ventricular arrhythmias have been documented before fatal events in most 
instances and SCD is usually attributed to ventricular fibrillation (82, 87-90). This 
suggests that sudden death is a risk primarily in those patients with mitral valve 
prolapse who show frequent premature ventricular contractions. Demonstration 
of  MVP as the only autopsy finding in some cases of sudden death (91, 92) 
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suggests the validity of this association even if does not prove mechanism or 
indicate cause and effect. Indeed, the strongest link between arrhythmias and 
sudden death in MVP comes from recognition of MVP as the only abnormality in 
survivors of cardiac arrest and in patients referred for management of refractory, 
symptomatic complex ventricular arrhythmias (93).  
Although the risk of  SCD in MVP is very low, with an estimated yearly rate 
of  0.4 %, the incidence is still twice that expected in the general population (69). 
Despite a benign course of the disorder in most cases, predictive risk factors in 
patients with MVP have been lined out in clinical studies: in a long-term follow-up 
of 237 patients (mean duration of follow-up 6.2 years), Nishimura identified 
thickened and redundant mitral valve leaflets as a possible risk factor for sudden 
death or lethal complications (1.6% in higher risk groups versus 0.1%  per year in 
lower risk group) (72). Moderate to severe mitral valve regurgitation is a well 
recognized predisposing factor for arrhythmias and SCD. The combination of 
severe mitral regurgitation, complex ventricular arrhythmias and LV dysfunction 
identifies a patient subgroup at particularly high risk (69). However, it should be 
noted that among the survivors of potentially fatal arrhythmia with MVP, mitral 
regurgitation has not been commonly reported (82,93,94). This might suggest 
that the proportion of SCD from MVP potentially associated with regurgitation is 
less than that observed by Davies (75): the pathogenesis of arrhythmic SCD in 
MVP patients with mild or no mitral regurgitation remains to be determined. 
In the 2013, Ackerman investigates the prevalence of MVP and its association 
with ventricular arrhythmias in a cohort with “unexplained” out-of-hospital 
cardiac arrest. Ten patients had a bileaflet MVP among 24 idiopathic SCD (42%). 
The authors describe a “malignant” subset of patients with MVP who experienced 
life-threatening ventricular arrhythmias. This phenotype is characterized by 
bileaflet MVP, female sex, and frequent complex ventricular ectopic activity, 
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including premature ventricular contractions of the outflow tract alternating with 
papillary muscle or fascicular origin (95). 
 
 
Pathogenesis of arrhythmias in mitral valve prolapse 
Propensity for ventricular electrical instability has been related either to MVP 
in itself or to coexistent autonomic nervous system dysfunction (94), underlying 
cardiomyopathy (91,96,97) and or conduction system abnormalities (78).  
 
Regarding mitral valve-related mechanisms, electrical instability can be due to:  
1. the excessive traction on the papillary muscle by the prolapsing leaflets 
leading a mechanical stress and injury in the papillary muscle and in their 
insertional points (98,99).  
2. the mechanical stimulation of the endocardium by the elongated cordae 
tendineae, their impact may produce a mechanical stimulus producing a 
ventricular ectopic beat.  (100),  
3. endocardial friction lesions and their myocardial extension: due arise as a 
result of friction between chordae and the LV mural endocardium which, in 
some instances, may lead to fibrosis of the mural endocardium. during 
early diastole the leaflets (87). 
 
Of note, as previously described, Rizzon et al. observed how ventricular 
extrasystolic beats increase with the up-right position, exactly like the 
ausculatatory finding (101). In the 1997, Wilde studied a MVP patient with 
ventricular arrhythmias through intraoperatory endo and epicardic mapping: 
PVCs mostly originated from papillary muscle, could be elicited by manual 
traction on the chordae of the posterior papillary muscle (99, 102).  
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In conclusion, previous studies mostly focused on the potential relationship 
between structural/mechanical mitral valve alterations  and  potentially lethal 
ventricular arrhythmias while demonstration of the role of ventricular myocardial 
substrates remains unknown.  
 
 
5.2 Aim 
 
The aim of this study is to disclose the myocardial substrate underlying life-
threatening arrhythmias in young adults with MVP, and demonstrate if it is 
detectable by contrast-enhanced cardiac magnetic resonance for risk 
stratification.  
 
 
 
5.3 Methods 
 
 Study design 
 
The study was divided in two arms: the first one (A, pathologic anatomy 
arm) was designed as a retrospective revision of SCD victims’ heart to analyse the 
pathological features of MVP-related deaths comparing with those for 
extracardiac causes; the second part (B, clinical arm) was designed as prospective 
enrolment of MVP patients to detect any difference in term of in vivo tissue 
characterization between arrhythmic and no arrhythmic patients.  
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A ) Pathologic anatomy arm:  SCD victims with MVP 
  
Population and  Protocol of investigation  
 From 1982 to 2013, all the hearts of SCD victims ≤40 years old occurring in 
the Veneto Region, were collected, pathologically investigated and preserved. 
SCD is herein defined as witnessed sudden and unexpected death occurring 
within 1 hour of the onset of symptoms or death of an individual who had been 
seen in stable condition <24 hours before being found dead (21,22). 
Demographic, clinical and pathologic data were recorded in the electronic 
database of the Registry of Cardio-cerebro-vascular pathology which acts as 
referral centre for SCD of the North-East of Italy, supported by the Regional 
Health System. Charts were evaluated for age, sex, symptoms and clinical history. 
All the hearts were re-examined carefully according to a standardized protocol 
(21). SCD cases were selected in whom MVP due to myxomatous valve disease 
was the only cardiac abnormality found at autopsy. Myxomatous valve disease is 
defined as increased leaflet length and redundancy, with interchordal hooding 
and leaflet billowing toward the left atrium and chordae tendineae elongation (8). 
In the absence of extracardiac (cerebral, respiratory) or mechanical cardiovascular 
(pulmonary thromboembolism, aortic rupture, chordal rupture with pulmonary 
edema) causes, the cause of death was considered cardiac arrhythmic. 
Exclusion criteria were clinical and/or pathologic evidence of more than mild 
mitral regurgitation, i.e. history of systolic murmur, echocardiographic report, and 
gross abnormalities such as left atrial dilatation, LV dilatation or chordal rupture.  
As controls, hearts from 15 sex and age-matched patients (10 females, mean age 
30 years, range 18-40), who died suddenly for extracardiac causes (8 cerebral and 
7 respiratory), were used.  
Formalin fixed hearts were restudied according to a protocol previously 
reported (21). Leaflet involvement (whether anterior, posterior or bileaflet) and 
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the presence of endocardial fibrous plaque (friction lesion) on the LV infero-basal 
wall were assessed. Multiple samples of the entire LV and right ventricular free 
walls and septum, including the papillary muscles (PMs), were obtained for 
histology. Additional samples were taken in the infero-basal free wall of the LV, 
underneath the posterior mitral valve leaflet. Five µm- thick sections were stained 
with Hematoxylin-Eosin, Weigert-van Gieson, Heidenhain trichrome and Alcian-
PAS. Morphometric analysis was performed using an Image-Pro Plus program 
(Version 4.0. Media Cybernetics, MD, USA) to quantify the fibrous tissue percent 
area of LV myocardium on Heidenhain trichrome stained sections at 25x 
magnification. Mean cardiomyocytes diameter was calculated on Haematoxylin-
eosin stained sections at 400x magnification.  Quantitative analysis was 
performed by two blind expert pathologists with an interobserver variability <5%. 
 
 
B)  Clinical arm : MVP patients with ventricular arrhythmias 
 
Population and  Protocol of investigation  
The study included consecutive patients referred to the Inherited 
Arrhythmic Cardiomyopathy Unit of our Clinic, from 2010 to 2013 with complex 
ventricular arrhythmias detected on the basis of 12-lead 24-hour Holter 
monitoring and echocardiographic diagnosis of MVP, defined as >5 mm 
thickening and >2-mm displacement of one or both mitral leaflets into the left 
atrium as viewed in the LV outflow tract orientation (23). Twelve-lead ECG 24 
hours Holter monitoring was requested due to the presence of either arrhythmic 
symptoms or 12-lead ECG changes. Complex ventricular arrhythmias consisted of 
ventricular fibrillation (VF) and ventricular tachycardia (VT), either non-sustained 
or sustained (24). The control group consisted of MVP patients with minor 
ventricular arrhythmias, i.e. isolated ventricular premature beats (VPB), couplets 
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and bigeminal VPB. Exclusion criteria were significant mitral valve regurgitation, 
tricuspid dysplasia or regurgitation, evidence of other cardiomyopathy or 
congenital heart abnormalities, hemodynamic unstable conditions and 
contraindication to CMR.  The study was approved by the institutional review 
board, and all patients gave their informed consent. 
All patients underwent cardiovascular evaluation including physical 
examination, 12-lead electrocardiogram (ECG), 2D-transthoracic 
echocardiography, 12-lead 24-hour Holter monitoring and CMR. Coronary 
angiography was performed in selected cases. The 12-lead ECG at rest and the 24-
hour Holter monitoring were independently assessed by two experienced 
observers who were blinded to patient data. 
The standard 12-lead ECG was recorded at rest; the following parameters 
were collected: PQ interval, QRS duration, ST-segment abnormalities, presence of 
T waves abnormalities (including inversion and biphasic morphologies, with 
corresponding regional distribution), QT corrected (QTc) duration according with 
Bazett’s formula, QT dispersion, QT peak, presence of supraventricular premature 
beats (SVPBs) and finally, presence and morphology of VPBs. Twelve-lead 24-hour 
Holter monitoring was performed in all, with collection of the following 
parameters: presence of atrio-ventricular block, ST-segment abnormalities, 
number of SVPBs, number and morphology of VPBs. Non-sustained VT was 
defined as ≥ 3 consecutive VPBs with a rate > 100 bpm that lasted <30 seconds 
during 24-hour Holter monitoring. Sustained VT was defined as tachycardia 
originating in the ventricle with rate >100 beats/minute and lasting >30 seconds 
or requiring an intervention for termination. 
Cardiac magnetic resonance was performed on a 1.5-Tesla scanner 
(Magnetom Avanto, Siemens Medical Solutions, Erlangen, Germany). All patients 
underwent detailed CMR study protocol (see Appendix for details), including ECG-
gated cine steady state free processing (SSFP) images and T1 inversion recovery 
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post-contrast sequence. The presence and location of LGE were independently 
assessed by two experienced observers who were blinded to patient clinical data. 
To exclude artefact, LGE was deemed present only if visible in two orthogonal 
views (long-axis and short-axis). LGE was identified using a signal intensity 
threshold of >5SD above a remote reference region. 
 
Statistical Analysis.   
Data are expressed as mean value ± standard deviation or median with 25 
to 75 percentiles for normally distributed and skewed variables, respectively. 
Normal distribution was assessed using Shapiro-Wilk test. Categorical differences 
between groups were evaluated by the chi-square test or the Fisher exact test as 
appropriate. Paired and unpaired t test were used to compare normally 
distributed continuous variables respectively obtained from the same patient and 
different patients; paired and unpaired signed rank test were used for skewed 
continuous variables. 
A value of P<0.05 was considered significant. Statistics were analysed with 
SPSS version 19 (SPSS Inc, Chicago, IL). The minimal detectable effect that can be 
detected at a significance level of 5% and power at 80% is equal to 1 (with non 
parametric test) for quantitative variables (Cohen’ Effect); for binary data an odds 
ratio of at least 10 can be detected if the proportion of the characteristic test is 
equal to 10% in the no CVA group (Fisher’s exact test). A sub-analysis was done by 
dividing the MVP population with complex ventricular arrhythmias into two sub-
groups, i.e. 3 beats run and  >3 beats run. 
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5.4 Results 
 
A) Pathologic anatomy arm:  SCD victims with MVP.  
Among 650 consecutive SCDs in young adults recorded in Cardiac Registry 
of the Veneto Region, 43 cases (26 females, median age 32 years, range 19-40) 
with MVP due to myxomatous valve disease were identified (7% of all SCD cases 
and 13% of women who died suddenly). Main clinical and pathologic data are 
reported in Table 13. SCD occurred mostly at rest or during sleep (n. 35, 81%). 
Twenty (47%) had an in vivo diagnosis of MVP, with auscultatory click in 18 (90%) 
and palpitations in 14 (70%). Nine (21%) were under beta-blockers therapy due to 
non sustained ventricular arrhythmias. ECG was available in 12 (28%), showing 
negative /isodiphasic T waves on inferior lead in 10/12 (83%) (Figure 9A,B); all had 
documented ventricular arrhythmias with right bundle branch block (RBBB) 
morphology (100%).  
Macroscopically, MVP cases and controls did not differ in terms of heart 
weight, LV wall and septal thickness (all p=NS).  
In SCD cases with MVP, mitral valve leaflets were always redundant, thick and 
elongated, with either isolated posterior (n. 13, 30%) or bileaflet (n.30, 70%) 
involvement (Figure 9C). The involvement of the posterior leaflet was diffuse in 
23 (53%) and confined to the medial scallop in 20 (47%). Endocardial fibrous 
plaques in the postero-lateral wall were found in 25 (58%). At histology, diffuse 
myxoid degeneration of the spongiosa layer with Alcian PAS positive 
proteoglycans deposits, extending to the fibrosa and chordae tendineae, 
supported the gross diagnosis of MVP. 
Microscopic examination of the LV myocardium showed an increase of 
endo-perimysial fibrosis and patchy replacement-type fibrosis at the level of PMs 
and adjacent free wall in all (Figure 9D,E and Figure 10). Similar findings, with a 
subendocardial-midmural layer distribution, were detected in the infero-basal 
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wall, underneath the posterior mitral valve leaflet, in 38 cases (88%). The mean 
fibrous tissue per cent area in SCD victims with MVP was 30.5% at the level of 
PMs and 33.1% in the infero-basal wall myocardium (vs. 6.3% and 6.4% 
respectively, in controls, p<0.001). In the same areas, the cardiomyocytes showed 
an increased diameter (19.2±6.0 micron vs. 12.8±0.4, p<0.001) and dysmorphic 
and dysmetric nuclei. 
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Table 13. Clinical and pathologic features of 43 patients who died 
suddenly with MVP due to myxomatous degeneration  
Variables 
SCD due to MVP 
43 patients 
Control 
15 patients 
Age, years median (range) 32 (19-40) 30 (18-40) 
Female, n (%) 26 (61) 10 (67) 
Athletes, n (%) 4 (9) 2 (13) 
Marfan stigmata, n (%) 2 (5) 0 
Pectus excavatum, n (%) 2 (4) 0 
Pregnancy, n (%) 2/26 (8) 1/10 (10) 
Circumstances of SCD, n (%) 
- on emotion/effort 
 
8 (19) 
 
4 (27) 
- at rest 
- during sleep 
30 (70) 
5 (12) 
9 (60) 
2 (13) 
12 lead ECG available, n (%) 
Inverted/biphasic T wave D2, D3, aVF n (%) 
12 (28) 
10 (83) 
5 (33) 
0 
VAs, n (%) 12 (28) 0 
VAs morphology, n (%) 
- RBBB  
 
12 (100) 
 
0 
- LBBB 8 (67) 0 
Antiarrhythmic therapy, n (%) 9 (21) 0 
Gross features   
Heart weight (g), mean ±SD* 357±53 323±42 
LV wall thickness (mm), mean±SD 12.6±1.3 12.5±3.6 
VS thickness (mm), mean±SD 13.0±0.8 12.6±0.7 
Patent foramen ovale, n (%)* 
Oval fossa aneurysm, n (%) 
25 (58) 
10 (23) 
4 (27) 
1 (6) 
Posterior MVP, n (%) 
Bileaflet MVP, n (%) 
13 (30) 
30 (70) 
0 
0 
Endocardial fibrous plaque, n (%) 25 (58) 0 
Histology features   
LV scar   
- papillary muscles, n (%) 43 (100) 0 
-infero-basal wall, n (%) 38 (88) 0 
Fibrous tissue /myocardium (% area)   
- papillary muscles, mean ± SD † 30.5±10.7 6.3±1.6 
- infero-basal wall, mean ± SD † 33.1±7.6 6.4±1.4 
Cardiomyocytes diameter (µm),  mean± SD † 19.2±6.0 12.8±0.4 
Abbreviations: LV= Left Ventricle; MVP= mitral valve prolapse; RBBB= right bundle branch block; 
SCD= sudden cardiac death; VAs= ventricular arrhythmias; VS= ventricular septum. 
† p<0.001 
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B) Clinical arm: MVP patients with ventricular arrhythmias.  
The baseline clinical, electrocardiographic and functional and 
morphological CMR findings are summarized in Table 14. Fourteen MVP patients 
with minor ventricular arrhythmias, i.e. isolated ventricular premature beats 
(VPB), couplets and bigeminal VPB served as controls. 
Thirty MVP patients (median age 41, range 28-43 years) with complex 
ventricular arrhythmias, i.e.  ≥ 1 episode of VF (n.2) and VT (n.28) - either non-
sustained (n.27) or sustained (n.1)- on 12-lead 24-hour Holter monitoring were 
collected. VT of LV origin (RBBB morphology) was present in all, with either 
inferior (43%) or superior (87%) axis.  Among the 27 patients with non-sustained 
VT, the mean length in beats was 4 (ranging from 3 to 11 beats) and 15 (55%) had 
non-sustained VT ≥4 beats. Complex ventricular arrhythmias occurred at rest in 
26/30 (87%). All patients had normal QTc (mean 423, range 409-440). Exercise 
stress test was performed in 20 and was negative for effort-induced ventricular 
arrhythmias. 
Bileaflet MVP was present in 21 (70%) patients with complex ventricular 
arrhythmias vs. 5 (36%) of controls (p=0.031). On post-contrast sequences, LV-
LGE was identified in 28 (93%) vs. 2 (14%) (p<0.001). 
 The LGE was localized on the PMs in 25 patients (83%), with a mid-apical 
distribution in 16 and/or basal adjacent free wall in 24 cases; and on the LV 
infero-basal segment, underneath the posterior valve leaflet, in 22 (73%) (Figure 
11A-D).  A segmental endocardial LGE, featuring the fibrous plaque, was found in 
12 patients (40%). At quantitative analysis of LV LGE , the median LV LGE% was 
1.2 in MVP with complex ventricular arrhythmias vs. 0 in in MVP without (p<0.01). 
Two MVP patients experienced aborted SCD due to VF despite the use of 
anti-arrhythmic drug therapy with beta-blockers due to previous evidence of SVT.  
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Detailed invasive and non-invasive clinical and instrumental evaluation ruled out 
cardiac causes other than MVP. Both patients had ventricular arrhythmias with 
RBBB pattern and superior axis and T waves abnormalities on inferior leads. CMR, 
performed 6 and 10 months before aborted SCD, revealed LV LGE of PMs and of 
the infero-basal wall underneath the posterior mitral leaflet (Figure 11 E,F). Both 
patients received an implantable cardioverter defibrillator (ICD). One patient had 
pre-syncopal episodes despite antiarrhythmic therapy with bisoprolol. She 
underwent electrophysiological study with induction of sustained VT with the 
same RBBB morphology of VPBs (Figure 12A-C). The CMR showed a non-ischemic 
LGE pattern in the LV infero-basal wall (Figure 12D). She also underwent ICD 
implantation. 
Of these three patients implanted with ICD (mean follow-up 10 months), two had 
NSVT: one patient with spontaneous interruption and the other one requiring 
anti-tachycardia pacing. 
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Table 14. Clinical, ECG and CMR features of 44 patients with MVP  
Abbreviations: SCD: sudden cardiac death; VPB: ventricular premature beats; NSVT: non sustained 
ventricular tachycardia; SVT: sustained ventricular tachycardia; VF: ventricular fibrillation; CVA: Complex 
ventricular arrhythmias; LBBB: left bundle branch block; RBBB: right bundle branch block. 
Data are presented as median (1st-3rd quartiles) or N (%). 
 
 
 
 
 
 
 
 
Variables 
MVP  
with CVA 
30 pts 
MVP  
without CVA 
14 pts 
p 
Age, years median (range) 41 (28-43) 51 (24-64) 0.44 
Female, n (%) 22 (73) 7 (50) 0.18 
Symptoms, n (%) 
- aborted SCD 
- palpitations 
- syncope 
- chest pain 
- dyspnea 
 
2 (7) 
15 (50) 
2 (7) 
2 (7) 
2 (7) 
 
0 
5 (36) 
0 
1 (7) 
1 (7) 
 
- 
0.52 
1.00 
1.00 
1.00 
Therapy, n (%) 
- Beta-blockers 
- Sotalol 
- Other antiarrhythmic  
 
13 (43) 
3 (10) 
1 (3) 
 
6 (43) 
0 
1 (7) 
 
1.00 
0.54 
0.54 
12 lead ECG    
Inverted/biphasic T wave, n (%) 
- D2, D3, aVF 
- D1, aVL 
10 (33) 
9 (30) 
2 (7) 
3 (21) 
2 (14) 
1 (7) 
0.5 
0.46 
1.00 
QTc duration, msec 423 (409-440) 412(394-432) 0.19 
ECG-Holter monitoring    
- VPB, n (%) 30 (100) 8 (57) <0.01 
- Bigeminal VPB 11 (37) 3 (21) 0.49 
- NSVT, n (%) 27 (90) 0 - 
SVT, n (%) 1 (3) 0 - 
VF, n (%) 2 (7) 0 - 
CVAs morphology, n (%) 
- LBBB inferior axis 
- LBBB superior axis 
- RBBB inferior axis 
- RBBB superior axis 
 
 0 
1 (3) 
13 (43) 
26 (87) 
 
0 
0 
0 
0 
 
- 
- 
- 
- 
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Table  14. Continued 
Abbreviations: LV:left ventricle; RV right ventricle; EF= Ejection Fraction; EDV = End-Diastolic 
Volume; MV: mitral valve; LGE= Late Gadolinium Enhancement. 
Data are presented as median (1st-3rd quartiles) or N(%). 
 
Variables 
MVP  
with CVA 
30 pts 
MVP  
without CVA 
14 pts 
p 
CMR Morpho-functional Findings    
   LV EDV, ml/m2 91 (89-103) 91 (83-91) 0.13 
   LV EF, % 64 (60-65) 66 (64-69) <0.01 
   LV mass, gr/m2 62 (60-63) 63 (49-63) 0.48 
   RV EDV, ml/m2 77 (71-79) 77 (76-78) 0.35 
   RV EF, % 64 (61-66) 64 (64-66) 0.43 
   Posterior MVP, n (%) 
   Bileaflet MVP, n (%) 
9 (30) 
21 (70) 
9 (64) 
5 (36) 
0.05 
0.05 
   Lengths MV leaflets, mm 
- Anterior 
- Posterior 
 
21 (19-26) 
16 (13-18) 
 
20 (17-25) 
11.4 (9-14) 
 
0.32 
0.02 
   Prolapse distance, mm 
- Anterior leaflet 
- Posterior leaflet 
 
5 (2-8) 
8 (4-12) 
 
1 (0-3) 
2 (2-4) 
 
0.01 
<0.01 
CMR Post-contrast Findings    
  LV LGE  
- papillary muscles  
- infero-basal wall 
28 (93) 
25 (83) 
22 (73) 
2 (14) 
2 (14) 
1 (7) 
<0.01 
<0.01 
<0.01 
LV LGE amount (%) 1.2 (0.8-2.1) 0 <0.01 
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Figure 9. SCD in a 36 years old woman with in vivo diagnosis of MVP. A,B) 12-lead basal ECG at 
the time of emergency department admission for palpitations. Single and coupled VPBs with 
RBBB morphology are present; note the negative T wave on the inferior leads. At 24 hour 
Holter-ECG (B) NSVT is also recorded; C) At gross examination, myxomatous degeneration of 
both leaflets of the mitral valve with elongated chordae is visible; D,E). At histology, severe 
myxoid thickening of the posterior mitral valve leaflet and myocardial fibrosis of the LV infero-
basal wall (D) and PM (E). 
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Figure 10. Histology of three representative SCD cases with MVP. Myocardial scarring is visible 
at the level of the infero-basal LV free wall, underneath the posterior mitral valve leaflet (A,B,C) 
and of the PMs plus adjacent free wall (D,E,F). Close-up of the scarring areas showing endo-
perimysial and patchy replacement-type fibrosis with interspersed cardiomyocytes (G,H,I).  
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Figure 11 CMR findings in MVP patients with complex ventricular arrhythmias and aborted SCD.   
A,B) A 30 years old woman with MVP and complex ventricular arrhythmias. LGE of the PM is 
visible on mid-short axis view (A). The 12 lead ECG (B) shows the presence of NSVT with RBBB 
morphology originating from the posterior PM (superior axis).  C,D) A 33 years old woman with 
MVP and complex ventricular arrhythmias. LGE of the LV infero-basal region, underneath the 
posterior valve leaflet, with endocardial-midmural extension, is visible on 3-chamber long axis 
view (C). The 12 lead ECG demonstrates NSVT with RBBB morphology originating from the LV 
infero-basal wall near the mitral annulus (inferior axis) (D).  E, F) A 38 years old man with MVP 
and aborted SCD. CMR, performed 6 months before cardiac arrest, shows LGE in the infero-
basal region of the LV on long-axis view (E). ECG recording of polymorphic SVT degenerating 
into VF (F). 
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Figure 12 . A 34 years old woman with pre-syncopal episodes despite antiarrhythmic drug 
therapy. 
A) Basal ECG shows isolated VPBs with two RBBB morphologies, indicating a LV origin from the 
PMs and the infero-basal wall close to the mitral anulus.   B,C)  Electro-physiologic study with 
programmed stimulation and induction of sustained VT with the same morphology of VPBs 
originating from the posterior mitral annulus, terminated by electrical cardioversion.   
D)  On CMR, LGE at the level of the LV infero-basal wall is visible. 
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5.5 Discussion and conclusions 
 
MVP is an under-recognized cause of SCD in young adults, accounting for 
7% of total fatal events and 13% of female victims in our large Cardiac Registry 
experience. Clear cut evidence of a substrate of electrical instability in MVP is 
herein provided for the first time and consists of myocardial scarring targeting the 
PMs and the infero-basal LV free wall, underneath the posterior leaflet, well in 
keeping with the site of origin of RBBB-type ventricular arrhythmias, showing 
either inferior or superior axis. The LV myocardial fibrosis observed at histology in 
SCD victims was then confirmed in the clinical arm of the study, with evidence of 
LGE at CMR in arrhythmic MVP patients, thus pointing to a promising role of this 
non invasive technique for risk stratification beyond traditional prognostic 
markers. 
In MVP series with prolonged ECG recording, a variable prevalence of 
ventricular arrhythmias has been reported (80-82), reflecting the different MVP 
definition, the population studied and the complexity of ventricular arrhythmias 
considered. In particular, the clinical evidence of hemodynamically important 
regurgitation greatly impacts on the occurrence of ventricular arrhythmias (69).  
However, the detection of MVP in survivors of life-threatening arrhythmias 
suggests that a true association between hemodynamically uncomplicated MVP 
and arrhythmic SCD may exist (76). Thus, we decided to focus on "pure" MVP, 
excluding MVP associated with valve incompetence and LV remodelling, not to 
defile the message and over-reporting ventricular arrhythmias. In the recent 
study of malignant MVP by Sriram et al (95), frequent VPBs originated from the 
outflow tract and PMs. Moreover, electrophysiology mapped the site of origin to 
the PMs, the LV outflow tract and the mitral annulus, as to suggest that VPBs 
arising close to the prolapsing leaflet and adjacent structures are the arrhythmic 
triggers.  
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From a pathophysiologic perspective, the mechanism of ventricular 
arrhythmias and SCD in MVP patients with trivial or absent mitral regurgitation 
remains speculative (76). MVP-related factors have been first advocated, such as 
the excessive traction on the PMs by the prolapsing leaflets; the mechanical 
stimulation of the endocardium by the elongated chordae, with after 
depolarization-induced triggered activity; the diastolic depolarisation of muscle 
fibres in redundant leaflets with triggered repetitive automaticity; and the 
endocardial friction lesions with their extension into the myocardium (98-100). 
Moreover, the coexistence of extravalvular diseases has been suggested, 
including autonomic nervous system dysfunction (94), conduction system 
abnormalities (78) and occult cardiomyopathies (77-91).  
Previous pathology studies in MVP patients dying suddenly mostly focused 
on mitral valve structural alterations, suggesting a role for annular circumference, 
leaflets length and thickness and presence and extent of endocardial plaques 
(75,87-89).  Surprisingly, no investigation did systematically address the LV 
myocardium in MVP patients dying suddenly to search for the substrate of 
electrical instability, except for a few anecdotic cases (87,90,99,124). For the first 
time, we extended the histopathology investigation beyond the valve in all SCD 
cases and provided convincing evidence of fibrosis in the LV myocardium which is 
closely linked to the mitral valve, i.e. the PMs with adjacent free wall and the 
infero-basal wall. The LV myocardial scarring is qualitatively different from that 
observed in ischemic heart disease, where it is usually compact and confluent, 
being instead patchy and interspersed within surviving, hypertrophic 
cardiomyocytes. Furthermore, we herein demonstrate that CMR detects LV- LGE 
in MVP patients with complex ventricular arrhythmias, overlapping in vivo the 
histopathologic features observed in SCD victims. At the level of PMs, two LGE 
deposition sites have been found, i.e. the mid-apical portion and the 
base/adjacent LV wall. Although PMs LGE has been reported by Han et al (111) in 
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MVP patients with a history of arrhythmias, most of these patients had moderate 
to severe mitral regurgitation. While confirming these data in purely arrhythmic 
MVP patients without hemodynamic impairment, we first provide convincing data 
on the presence of LGE in the infero-basal LV wall. The arrhythmogenic role of the 
LV myocardial scarring is supported by the morphology of arrhythmias and by 
electrophysiological studies in MVP indicating that the most common site of VPB 
origin is the infero-basal LV wall (95).  
Many of the studies of CMR for risk stratification of SCD provide estimates 
of the percent of myocardium affected, with the notion that larger burdens of 
LGE are more relevant. Our preliminary quantitative data suggest that the volume 
of LV scarred tissue in MVP is relatively small but still significant. Thus, at 
difference from other conditions, LGE in MVP patients still predicts SCD risk 
despite the small burden. These findings are similar to those observed in dilated 
cardiomyopathy, where we demonstrated that LV-LGE is a powerful and 
independent predictor of malignant arrhythmic prognosis, while its amount and 
distribution do not provide additional prognostic value (5). Further studies with 
higher number of MVP patients are needed to confirm these preliminary 
quantitative data of LV LGE in MVP. 
Since the early descriptions, abnormal LV contraction pattern and ECG 
abnormalities suggested that MVP has a significant myocardial involvement (116-
119). The hypothesis that the so-called “MVP syndrome” is a cardiomyopathy, 
where regional hypercontractility acts as the primum movens of mitral valve 
geometry disruption, with abnormal tension on the chordae and leaflets and 
secondary increase in myxomatous tissue and leaflet thickening, has been even 
advanced. Our pathology and CMR data support the theory that LV abnormalities 
are rather the consequence of MVP, due to a systolic mechanical stretch of the 
myocardium closely linked to the valve, i.e. PMs and infero-basal wall, by the 
prolapsing leaflets and elongated chordae, accounting for a localized hyper-
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contractility, with myocyte hypertrophy and injury leading eventually to fibrous 
tissue repair. The increased cardiomyocyte diameter in the same areas showing 
replacement-type fibrosis is in keeping with this theory.  
Considering that performance of CMR in every case of MVP would be an 
expensive proposition, our study indicates some clinical markers that could target 
a high-risk subgroup of MVP patients destined for screening by CMR.  These 
include ECG depolarization abnormalities on inferior or infero-lateral leads, 
complex ventricular arrhythmias (≥ 3 beats run) with RBBB morphology on 12-
lead ECG Holter monitoring and a history of pre-syncope, syncope and aborted 
SD. 
Finally, we recognize that our data support an association between anatomic 
substrate and risk, in an entity, i.e. MVP, that is under appreciated as a cause of 
SCD and also has a low enough incidence that any marker of increased risk might 
be of significant value to the clinician. 
Current clinical practice suggests the use of generic drugs therapy (i.e. beta-
blockers) in arrhythmic MVP patients. The fact that 21% of young adult SCD 
victims and two living MVP patients had aborted SCD despite beta-blocker 
therapy is intriguing.  Prospective and multicentre studies are warranted to 
support the role of CMR and electrovoltage mapping for risk stratification and to 
assess the efficacy of traditional antiarrhythmic therapy and targeted catheter 
ablation in selected cases.  
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Limitations of the study.  
The small number of enrolled MVP patients without complex ventricular 
arrhythmias could represent a limitation of the paper. However, we should 
recognize that it is difficult to collect “pure” MVP patients without either valve 
incompetence or ventricular arrhythmias. Prospective and multicentre studies 
enrolling a higher number of MVP with and without complex ventricular 
arrhythmias are needed to evaluate the exact prevalence of LGE in overall MVP 
population.  
 
 
Conclusions.  
MVP is a not so rare cause of SCD in young adults and is the leading one in 
women. Arrhythmic MVP patients are mostly female with ventricular arrhythmias 
of LV origin and frequent repolarization abnormalities on inferior leads. The 
hallmark of arrhythmic MVP is fibrosis of PMs and infero-basal LV wall, which well 
correlates with arrhythmia morphology, pointing to a myocardial stretch by the 
prolapsing leaflets and elongated chordae. CMR allows the identification of this 
arrhythmic substrate and is a promising non-invasive tool for risk stratification 
and SCD prevention. 
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Chapter 6 
 
THE MITRAL VALVE PROLAPSE 
The functional substrates underlying fibrosis 
 
 
6.1 Introduction  
 
As reported before in details, arrhythmic MVP seems to be characterized by 
LV fibrosis at the level of papillary muscles (PM) and inferobasal wall. We 
provided evidence of this structural substrate for electric instability both by 
histopathology in sudden cardiac death SCD patients with myxomatous mitral 
valve and by LGE on contrast-enhanced CMR in arrhythmic MVP patients, with 
the morphology of arrhythmias well correlating with the site of scarring (103). 
Thus, we hypothesized a localized mechanical stretch on the LV myocardium by 
the prolapsing leaflets producing replacement-type fibrosis. Myxomatous mitral 
valve is characterized by leaflet thickening and redundancy, interchordal hooding, 
chordal elongation, and annular dilatation because of accumulation of 
proteoglycans (75). In 1986, Hutchins et al (104) first advanced a role of the mitral 
annular disjunction (MAD), defined as a separation between left atrial (LA) wall at 
the level of mitral valve junction and the LV free wall, in disease pathogenesis. 
According to their hypothesis, this peculiar anatomy of the mitral annulus could 
trigger a mechanical stress on the leaflets, leading to myxomatous degeneration, 
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as a consequence of an excessive mobility of valve apparatus. Although MAD has 
been evaluated in MVP patients with severe valve regurgitation (105), its role in 
arrhythmic MVP remains to be elucidated.  
 
 
6.2  Aim 
 
Because MVP is a relatively common echocardiographic finding and only a 
small proportion of MVP patients is characterized by ventricular arrhythmias, the 
aim was to assess whether morphological and functional characteristics of the 
mitral valve apparatus could explain the propensity in some patients to develop a 
regional LV fibrosis at risk of electric instability. In order to investigate this 
hypothesis, the in vivo data collected by clinical study have been confirmed by 
pathological study. 
 
 
 
6.3 Methods 
 
Study populations 
The study included consecutive arrhythmic patients (either right bundle 
branch block or polymorphic ventricular arrhythmias) referred to our Cardiology 
Clinic from January 2010 to July 2014 with echocardiographic diagnosis of MVP 
and who underwent CMR for the identification of LGE as previously defined. 
Complex ventricular arrhythmias consisted of ventricular fibrillation and 
ventricular tachycardia, either nonsustained or sustained. 
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MVP patients with LGE constituted our study population, whereas those 
without LGE, enrolled in the same period, served as control group. Patients with 
an echocardiographic diagnosis of MVP but without history of arrhythmias did not 
undergo CMR. Exclusion criteria were moderate-to-severe mitral regurgitation, 
tricuspid dysplasia or regurgitation, cardiomyopathies or congenital heart 
abnormalities, hemodynamic unstable conditions, and contraindication to CMR. 
The institutional review board approved the study, and all patients gave informed 
consent.  
The pathology arm of the study included SCD patients with MVP and LV 
fibrosis (103). Hearts from sex- and age-matched patients who died suddenly as a 
result of extracardiac causes served as controls. 
 
 
Protocols of investigation 
A) Clinical arm 
All patients underwent cardiovascular evaluation that included history, 
careful physical examination, 12-lead ECG, 2-dimensional transthoracic 
echocardiography, 12-lead 24-hour Holter monitoring, and CMR. Cardiac 
auscultation was performed in all patients, paying particular attention to the 
detection of midsystolic click and late systolic murmur, progressively anticipated 
in systole by postural changes (101,106,107). CMR was performed on a 1.5-T 
scanner (Magnetom Avanto, Siemens Medical Solutions, Erlangen, Germany). All 
patients underwent a detailed CMR study protocol (see appendix for details). 
On CMR, a series of morphofunctional parameters were carefully 
evaluated. MAD was defined as a separation between the LA-valve junction and 
the atrial aspect of the LV free wall (104). According to this definition, the length 
of MAD (or elongated mitral annulus) was measured from the LA wall–posterior 
MV leaflet junction to the top of the LV inferobasal wall during end systole (108) 
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(Figure 13A). In particular, the upper limit of MAD was defined at the level of P2 
scallop insertion to the LA wall, whereas the lower limit was defined at the level 
of LA connection with LV myocardium (105).  
All these measurements were calculated from the 3-chamber view for the 
LV outflow tract long-axis view, equivalent to the transthoracic parasternal long-
axis view, obtained by an image plane perpendicular to the mitral annular major 
axis centered at the aortic outflow track (109), and from 4-chamber view (110) 
(Figure 13) . According to previous studies on MVP (108-111), additional 
morphofunctional parameters were evaluated: 1) ventricular volumes; 2) lengths 
of MV leaflets; 3) prolapsed distance (measured as the maximum prolapsed 
distance during peak systole beyond the mitral annulus) (Figure 13B); 4) diastolic 
maximum MV leaflet thickness; 5) mitral annular diameter during end systole and 
end diastole; and 6) ratio of basal to midventricular end-diastolic wall thickness 
(Figure 13C).  
Finally, the presence of the so-called curling, defined as an unusual systolic 
motion of the posterior mitral ring on the adjacent myocardium (112), was also 
evaluated. When present, a quantitative assessment of curling was provided, by 
tracing a line between the top of LV inferobasal wall and the LA wall–posterior 
MV leaflet junction, and from this line a perpendicular line to the lower limit of 
the mitral annulus was traced and expressed in millimetres (Figure  13D). Curling 
was defined as severe when the value was higher than the median value.  
All these morphofunctional parameters were independently assessed by 2 
experienced observers who were blinded to clinical data. 
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Figure 13.Cardiac magnetic resonance measures in patients with mitral valve prolapse. A, On 3-
chamber, long-axis view, the length of mitral annulus disjunction (MAD; continuous white line) 
is measured from the left atrial (LA) wall–posterior MV leaflet junction to the top of the left 
ventricular (LV) inferobasal wall during end systole. B, On the same systolic frame, the 
prolapsed distance is measured as the maximum distance of the leaflet beyond the mitral 
annulus (white arrows). C, The LV thickness of basal and mid segments of the inferolateral wall 
is measured in the same long-axis view on diastole. D, The quantitative assessment of curling 
(white arrow) is provided by tracing a line between the top of LV inferobasal wall and the LA 
wall–posterior MV leaflet junction, and from this line, a perpendicular line to the lower limit of 
the mitral annulus during end systole. 
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B) Pathological Anatomy arm 
Formalin-fixed hearts from patients who died suddenly with myxomatous 
MV degeneration and LV replacement-type fibrosis at the level of PM and 
inferobasal wall were examined to assess the presence of MAD, as previously 
defined. To this aim, longitudinal full thickness samples of the left atrioventricular 
junction along the lateral and posterior walls, including the LA wall, the LV wall, 
and the attachment of the posterior MV leaflet, were obtained for histology. Five-
micrometer-thick sections were stained with hematoxylin–eosin, Weigert–van 
Gieson, and Heidenhain trichrome. Morphometric analysis was performed with 
an Image-Pro Plus program (version 4.0. Media Cybernetics) to measure the MAD 
at ×2 magnification expressed both in micrometers and millimeters. Quantitative 
analysis was performed by 2 blinded expert pathologists. 
 
 
Statistical Analysis 
Categorical data were expressed as number and percentage of population. 
Results were expressed as median and quartiles. In case of categorical variable, 
differences between groups were evaluated by the χ2 test or Fisher exact test as 
appropriate. Wilcoxon rank-sum test was used for quantitative variables. The 
interobserver agreement for CMR and histopathology measurements of MAD 
were evaluated with the Lin (113) Concordance Correlation Coefficient and the 
95% confidence interval calculated with the bootstrap method considering 2000 
resamplings. Ratio of basal to midventricular end-diastolic wall thickness was 
expressed both as continuous variable (millimeters) and as a cut off defined on 
the basis of median value. The linear correlation was expressed with Spearman 
correlation coefficient. In all the analyses, a value of P<0.05 was considered 
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statistically significant. Statistics were analyzed with SPSS version 19 (SPSS, Inc, 
Chicago, IL) and SAS 9.4 (SAS Institute, Inc, Cary, NC). 
 
 
6.4 Results 
 
A) Clinical arm 
The baseline clinical and CMR findings of the 36 (27 female patients; 
median age: 44 years) arrhythmic MVP patients with LV fibrosis identified as LGE 
are summarized in Table 15. The control group consisted of MVP without LGE 
(n=16; 6 female patients; median age: 40 years).  
A higher prevalence of midsystolic click (72% versus 38%; P=0.018), late systolic 
murmur (69% versus 25%; P=0.003), complex ventricular arrhythmias originating 
from the LV (32/36 [89%] versus 1/16 [6%]; P<0.001), and bileaflet MVP (26/36 
[72%] versus 5/16 [31%]; P=0.005) was found in MVP patients with LV LGE as 
compared with those without. Moreover, MVP patients with LGE had a longer 
MAD (median: 4.8 versus 1.8 mm; P<0.001) and higher prevalence of curling (34 
[94%] versus 3 [19%]; P<0.001). A representative case of a patient with curling 
and LV fibrosis is shown in Figure 14.  
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Figura 14 Representative case of arrhythmic MVP with mitral annular disjunction, curling, and 
late gadolinium enhancement (LGE). A 36-y-old woman with mitral valve prolapse and complex 
ventricular arrhythmias. On cine cardiac magnetic resonance (CMR) 3-chamber, long-axis view 
(diastolic frame A, systolic frame B), a mitral annulus disjunction is detectable; on contrast-
enhanced CMR, a midmural LGE in the LV inferobasal region under posterior valve leaflet is 
visible (C). The 12-lead ECG (D) shows a negative T wave in III-aVF. Nonsustained ventricular 
tachycardia with right bundle branch block morphology originating from the LV inferobasal wall 
near the mitral annulus is also recorded in the 24-h Holter ECG (E). 
 
 
 
The median value of the depth of curling was 3.5 mm in the overall 
population, with a statistically significant higher value in MVP patients with LGE 
(4.8 versus 0 mm; P<0.001). Using the median value as a cut off for severe curling, 
it was more prevalent in MVP patients with LGE (25% versus 1%; P<0.001). A 
linear correlation was found between MAD and curling (R=0.85; Figure 15) and 
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between MAD and extent of LGE (R=0.61; Figure 16). Patients with LV LGE 
showed an increased leaflet thickness both for anterior (median: 3.5 versus 3 
mm; P=0.008) and posterior leaflet (median: 4 versus 3 mm; P=0.001) and a more 
pronounced prolapsed distance (anterior prolapsed distance median value: 4.9 
versus 1 mm; P=0.004 and posterior prolapsed distance median value: 7.1 versus 
2.1 mm; P<0.001). The median value of ratio between basal and mid portion of 
lateral wall thickness was 1.5 in the overall population, with no differences 
between the 2 groups. By applying the median value of 1.5 as a cut off for 
increased ratio, it was more prevalent in the LGE MVP group (22 [61%] versus 4 
[25%]; P=0.016). Both end-systolic (median: 41.2 versus 31.5; P=0.004) and end-
diastolic mitral annular diameters (median: 35.5 versus 31.5; P=0.042) differed 
between the 2 groups with a paradoxical increase of the mitral annulus diameter 
during systole versus diastole in the LGE group. Patients with bileaflet MVP (n=31) 
had a longer MAD (4.8 versus 2.5; P<0.001), higher prevalence of curling (28 
[90%] versus 9 [43%]; P<0.001) and of LGE (26 [84%] versus 10 [48%]; P=0.005) as 
compared with patients with single (posterior) leaflet MVP (n=21). 
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Table 15. Clinical and CMR Characteristics. 
Variables 
MVP with  
LGE 
36 patients 
MVP without 
LGE 
16 patients 
p 
Age, years 44 (36-55) 40 (23-53) 0.351 
Female, n (%) 27 (75) 6 (38) 0.010 
Complex Ventricular Arrhythmias, n (%) 32 (89) 1 (6) <0.001 
Physical Examination 
Mid-systolic click 
Murmurs 
 
26 (72) 
25 (69) 
 
6 (38) 
4 (25) 
 
0.018 
0.003 
CMR Morpho-functional findings    
LV EDV, mL/m2 91 (89-99) 91 (81-93) 0.581 
LV EF, % 64 (60-65) 67 (65-71) 0.001 
LV mass, g/m2 62 (59-64) 63 (49-64) 0.691 
RV EDV, mL/m2 77 (70-80) 77 (75-83) 0.527 
RV EF, % 64 (62-68) 65 (64-68) 0.534 
Posterior MVP, n (%) 10 (28) 11 (69) 0.005 
Bileaflet MVP, n (%) 26 (72) 5 (31) 0.005 
Mitral leaflets thickness, mm 
Anterior 
Posterior 
 
3.5 (3-4) 
4 (3-4) 
 
3 (3-3) 
3 (2.5-3) 
 
0.008 
0.001 
LV lateral wall thickness, mm 
Basal segment 
Mid segment 
 
8 (6.1-8.9) 
5 (4-6) 
 
8 (7.1-9.1) 
5.3 (4.8-6.8) 
 
0.834 
0.154 
Ratio LV lateral mid/basal wall thickness 1.7 (1.3-2) 1.3 (1.2-1.5) 0.168 
LV lateral mid/basal wall ratio≥1.5, n (%) 22 (61) 4 (25) 0.016 
Prolapsed distance, mm 
Anterior leaflet 
Posterior leaflet 
 
4.9 (1.4-7.9) 
7.1 (4-11) 
 
1.0 (0-2.8) 
2.1 (2.0-3.7) 
 
0.004 
<0.001 
Mitral annular diameter, mm 
End-systolic 
End-diastolic 
Systolic-Diastolic variation 
 
41.2 (35.1-45.5) 
35.5 (31-38) 
6.2 (1.5-9.5) 
 
31.5 (29-36.5) 
31.5 (26-33.5) 
1.5 (0.2-4) 
 
0.004 
0.042 
0.016 
Length of MAD, mm 4.8 (3.2-7) 1.8 (0-3.8) <0.001 
Curling, n (%) 34 (94) 3 (19) <0.001 
Curling, mm 4.8 (3-6) 0 <0.001 
Severe curling  (≥3.5 mm), n(%) 25 (69) 1 (6) <0.001 
Abbreviation: EDV= end-diastolic volume; EF= ejection fraction; LV= left ventricular; MVP= 
mitral valve prolapse; MAD= mitral annular disjunction; RV= right ventricular. Categorical 
variables are presented as number of patients (%). Continuous values are expressed as median 
with 25% and 75%-iles. 
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Figure 15 Relationship between length of mitral annular disjunction and curling in vivo. A 
significant correlation (R=0.85) between the depth of curling and length of mitral annulus 
disjunction (MAD; both expressed as mm) on cardiac magnetic resonance is observed. LGE 
indicates late gadolinium enhancement. 
 
 
 
 
              
Figure 16 Relationship between length of mitral annular disjunction and amount of late 
gadolinium enhancement in vivo. A significant correlation (R=0.61) between the length of 
mitral annulus disjunction (MAD; expressed as mm) and the amount of late gadolinium 
enhancement (LGE; expressed as percentage of left ventricular [LV] mass) on cardiac magnetic 
resonance is observed. 
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On the basis of auscultatory findings, 32 MVP patients had a midsystolic 
click. Patients with midsystolic click showed an elongated MAD (median 4.8 
versus 3 mm; P=0.1), curling (84% versus 50%; P=0.008), severe curling (≥4 mm in 
63% versus 30%; P=0.023), LGE (81% versus 50%; P=0.018), and complex 
ventricular arrhythmias (75% versus 45%; P=0.029) as compared with those 
without click (Table 16) 
 
Table 16. CMR findings according to mid-systolic click on auscultation. 
 
Variables 
MVP with 
mid-systolic 
click 
32 patients  
MVP 
without mid-
systolic click 
20 patients  
 
p 
Length of MAD, mm 4.8 (3-7) 3 (2.3-4.8) 0.089 
Curling, n (%) 27 (84) 10 (50) 0.008 
Curling, mm 4.8 (1.8-5.5) 1.2 (0-4) 0.009 
Severe curling  (≥3.5 mm), n(%) 20 (63) 6 (30) 0.023 
LGE, n(%) 26 (81) 10 (50) 0.018 
MV annulus systolic variation, mm 5.5 (0.8-9.5) 2.5 (-1.4-5.2) 0.042 
Bileaflet MVP, n (%) 22 (69) 9 (45) 0.089 
Prolapsed distance anterior leaflet, mm 4.9 (1-7.4) 1.8 (0-4.1) 0.050 
Prolapsed distance posterior leaflet, mm 6.3 (3.5-11.4) 3.7 (2.1-5.8) 0.032 
Complex Ventricular Arrhythmias, n (%) 24 (75) 9 (45) 0.029 
LGE= Late Gadolinium Enhancement; MAD= mitral annular disjunction; MVP=mitral valve 
prolapse. Categorical variables are presented as number of patients (%). Continuous values are 
expressed as median with 25% and 75%-iles. 
 
The 37 MVP with curling had a higher prevalence of negative T waves (32% 
versus 13%; P=0.3), LGE (92% versus 13%; P<0.001), and amount of LGE (1.6% of 
LV mass versus 0; P=0.001) as compared with those without curling. 
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B) Pathological arm 
Mitral valve leaflets were redundant, thick, and elongated, with either 
isolated posterior (n=18, 36%) or bileaflet (n=32, 64%) involvement in a 
consecutive series of 50 SCD Patients (30 female patients; median age 36 years) 
with MVP and LV fibrosis. SCD patients with MVP had a longer MAD as compared 
with a series of 20 (14 female patients; median age: 34 years) SCD hearts without 
MVP (median: 3 versus 1.5 mm; P≤0.001; Figure 17). 
 
 
Figure 17 Length of MAD in SCD patients: controls vs mitral valve prolapse (MVP) patients. The 
length of MAD (measured as micrometers) in SCD patients with MVP is significantly higher than 
in controls (A). Representative histology of the mitral annulus showing the absence of MAD in a 
SCD control (B) as compared with an elongated MAD in a SCD patients with MVP (C). 
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6.5  Discussion and conclusions 
 
Since arrhythmic MVP is characterized by myxomatous MV and LV fibrosis 
at the level of PM and inferobasal wall, as demonstrated before (103), the 
present study shows that MAD and systolic curling of the posterior MV leaflet are 
associated with LV fibrosis, accounting for the excessive mobility of the MV 
apparatus and systolic stretch of the myocardium closely linked to the valve. The 
specific distribution of LV fibrosis, as demonstrated by CMR, was in fact in keeping 
with a mechanical injury of the myocardium caused by the continuous traction of 
the prolapsing leaflets and elongated chordae. 
The mitral annulus is a component of the MV apparatus and consists of a 
cord-like ring of collagen and elastic fibers distributed along the atrioventricular 
junction and giving support to the MV leaflets. It is conventionally divided into 
anterior and posterior portions, although the real annulus is the one that serves 
as hinge point for the mural posterior leaflet of the MV. The concept of MAD was 
originally introduced by Bharati (78) and then systematically investigated by 
Hutchins (104) in the 1980s, referring to an anatomic variation of the fibrous 
mitral annulus. In the latter pathological study of 900 hearts from adult autopsies, 
25 (3%) had a morphologically typical floppy MV and 23 of them (92%) showed a 
MAD. This was defined as a variation in the attachment of the posterior MV 
leaflet, that accounts for a wide separation between the LA wall–MV junction and 
the LV attachment (104). In other words, the posterior annulus seemed stretched 
curtain-like, as compared with the normal cord-like structure (114). In the same 
series, MAD was rare in hearts without floppy MV (42 cases, 5%). Because these 
patients were significantly younger than those with a floppy MV, the authors 
suggested that this anatomic variation could play a role in the pathogenesis of 
98 
 
myxomatous valve degeneration, by means of increased mechanical stress 
induced by the excessive mobility of the MV apparatus (104). 
 
To the best of our knowledge, this structural abnormality of the mitral 
annuls remained mostly forgotten and just a matter of speculation for 
pathologists up to 2005, when Eriksson (105) observed MAD by direct surgical 
inspection in some patients undergoing MV repair with advanced myxomatous 
disease. By applying a standardized transesophageal echocardiography protocol, 
the same authors found a 98% of prevalence of MAD in a surgical series of MVP 
patients with severe mitral regurgitation. Furthermore, a positive correlation 
between the severity of MAD and the number of diseased MV scallops was 
demonstrated, supporting the concept of an association between MAD and the 
severity of MVP. These authors also emphasized that impact of MAD on mitral 
annular function. In fact, in advanced MV disease, they did not observe any 
significant diastolic–systolic change in annular diameter, suggesting that not only 
mitral annulus geometry but also function is altered with loss of systolic 
contraction. On the basis of these findings, and the possible increased failure risk 
of MV repair because of an unrecognized MAD, Eriksson (105) modified their 
surgical repair technique to optimize long-term results. 
Later on, Carmo (108) for the first time demonstrated that MAD is easily 
detectable and measurable also by routine transthoracic echocardiography. Using 
this technique in patients with myxomatous MV, including different degrees of 
mitral regurgitation, they found a MAD prevalence of 55%, more common in 
women (63% versus 38%) and often associated with chest pain. In this study, an 
association between MAD and mitral annulus dysfunction was also evidenced, 
with a paradoxical systolic increase of the mitral annulus diameter. Noteworthy, 
although sustained ventricular arrhythmias were not detected, an increased 
frequency of premature ventricular beats and nonsustained ventricular 
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tachycardia in patients with MAD versus those without was reported: the wider 
the magnitude of MAD, the higher the incidence of nonsustained ventricular 
tachycardia. In our study, we provide the evidence that MAD is associated with 
arrhythmic MVP, a theory previously only supposed (104,108). In our series, a 
quantifiable MAD was always detectable in both arrhythmic MVP patients with LV 
LGE (median: 4.8 mm) and SCD cases with LV fibrosis (median: 3 mm), mostly 
located close to the annulus in the inferobasal wall. The slight difference between 
CMR and histopathology MAD values is most likely the consequence of artifacts 
because of partial volume effects, as previously described in other 
echocardiographic studies (114,115). Moreover, the higher values reported by 
Eriksson (105) (10±3 mm) can be explained by their peculiar study population that 
included patients with severe mitral regurgitation, that, on the contrary, were 
excluded in our series. Interestingly, Carmo (108), by studying MVP patients with 
the entire spectrum of mitral regurgitation, demonstrated an intermediate value 
of MAD of 7.4±8.7 mm. The motion of the mitral annulus is passive and 
determined by the contraction and relaxation of adjacent atrial and ventricular 
musculature. As consequence, in normal condition, the posterior mitral ring and 
its adjacent myocardium move downward and anteriorly in systole, in synchrony 
with the remainder of the LV (114). Gilbert et al (112) in 1976 provided the first 
echocardiographic demonstration of a peculiar functional abnormality of the 
mitral annulus in MVP patients, describing an unusual systolic curling of the 
posterior mitral ring on the adjacent myocardium, so that the systolic movement 
of the ring was primarily downward with little, if any, anterior motion, thus 
resulting in a curled appearance when visualized in real-time motion. The authors 
concluded that the cause of curling in MVP was uncertain because, differently 
from previous reports, they did not visualize LV motion abnormalities either by 
echocardiography or angiography. In our series of arrhythmic MVP patients, we 
demonstrate for the first time that curling of the mitral annulus is associated with 
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MAD and accounts for annular hypermobility. Furthermore, a linear correlation 
has been found between the length of MAD and the severity of curling. These 
data create a link between the hypothesis made by Hutchins (104) and early 
angiographic observations of contractility abnormalities in MVP patients 
characterized by an arrhythmic profile, thus advancing the hypothesis of MVP as a 
cardiomyopathic condition (96,116,117). 
A relative increase of the LV mass, which does not seem to be caused by 
mitral regurgitation, has been recognized in MVP since many years, suggesting 
that myocardial involvement is an integral part of arrhythmic MVP (118). On the 
basis of few observations of MVP patients with asymmetrical LV hypertrophy 
isolated to the inferobasal wall, Maron (119) even advanced the hypothesis of a 
novel form of hypertrophic cardiomyopathy. More recently, Zia (110) performed 
a CMR study demonstrating the existence of a relative concentric basal LV 
hypertrophy, focal and localized to the base in MVP patients as compared with 
controls. Moreover, they found a significantly increased ratio of basal to 
midventricular end-diastolic wall thickness mostly in the lateral wall, compared 
with all other segments. A positive correlation between the degree of relative 
basal LV hypertrophy and the excursion of the MV annulus, defined as the 
distance between the position of the annulus in end diastole and end systole, was 
also detected. All these findings are in keeping with a locally increased myocardial 
function adjacent to the prolapsed MV leaflet, eventually leading to focal 
hypertrophy of the LV base. The abnormal contractility of this LV region accounts 
in part for the so-called systolic curling motion. Noteworthy, original angiographic 
studies evidenced a bulging on the inferobasal wall, because of the abnormal 
contractility of the basal portion compared with the mid one, as to resemble the 
so-called ballerina-foot pattern (96, 120-125). In our arrhythmic MVP patients, we 
also found a relative hypertrophy of inferobasal wall, as compared with the 
adjacent mid portion. Moreover, a midmural LGE in the LV inferobasal wall was 
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demonstrated in 72% of cases, all with MAD and curling. On the contrary, in the 
study by Zia (110) no fibrosis as LGE was detectable in the context of basal 
hypertrophy. This discrepancy may be explained by the selection of MVP 
population, because we included MVP patients without mitral regurgitation, but 
with LGE and arrhythmic profile, differently from Zia who included retrospective 
patients with MVP and various degrees of valve regurgitation. 
Although we demonstrated the role of LV fibrosis as a substrate of electric 
instability in arrhythmic MVP, a systematic investigation of morphofunctional 
abnormalities of the MV apparatus, capable to explain why a subgroup of MVP 
patients develop LV fibrosis, was still missing. The present study clearly 
demonstrates that, in arrhythmic MVP patients, the MV is characterized by MAD, 
systolic curling, and myxomatous leaflets thickening. On the basis of our previous 
observations in arrhythmic MVP (103) and the results reported in this study, the 
following cascade of events can be hypothesized. MAD is the cause of systolic 
curling motion; this morphofunctional alteration represents the basis for 
paradoxical increase of the MV annulus diameter during systole, myxomatous 
degeneration of MV leaflets, and myocardial stretch in the LV inferobasal 
segment. Our data in the subset of patients with arrhythmic MVP confirm, and 
further extend, the previous observation made by Hutchins et al. (104). 
This impairment in the mitral annulus contractility not only influences the 
geometry and function of mitral ring and adjacent LV segments with relative 
hypertrophy but also involves a complex force balance of all MV components 
including PM. As a result of the abnormal contractility produced by MAD, the 
mechanical stretch is directly transmitted to PM that can also show LGE in the 
stretched areas. The regional area of hypercontraction, originally hypothesized 
and defined of unknown cause by Nutter (120), has a clear anatomic basis in the 
association of MAD with systolic curling. This association can increase wall stress 
in the inferobasal wall and PM, as evidenced by hypertrophy and replacement-
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type fibrosis, both documented at postmortem by histology and confirmed in vivo 
as LGE by CMR in our previous study. The frequent observation of T-wave 
abnormalities on inferolateral leads at 12-lead ECG possibly suggests a disturbed 
repolarization of the area with abnormal contractility, as previously advanced 
(95,101,103). 
The genesis of malignant arrhythmias in MVP probably recognizes the 
combination of the substrate (myocardial fibrosis) and the trigger (mechanical 
stretch) eliciting premature ventricular beats (99). Noseworthy (126) and Vaidya 
(127) reported a series of cases where the surgical correction of bileaflet MVP 
was associated with a reduction in malignant arrhythmia and appropriate 
implantable cardioverter defibrillator shocks. In other words, mitral valve repair 
could relieve the mechanical stretch of the myocardium, thus leading to a 
reduction, but no disappearance, of ventricular arrhythmias, as to confirm a key 
role of abnormal mechanical forces. When comparing bileaflet and single-leaflet 
MVP patients, the former have longer MAD and higher prevalence of curling and 
LGE. The fact that most of our arrhythmic patients had a bileaflet MVP is probably 
because of the entry criteria, since only patients with mild or absent mitral 
regurgitation were enrolled to exclude a confounding effect of hemodynamic 
impairment. In fact, it is likely that a retained coaptation of the leaflets does occur 
when both leaflets are involved. 
In the past, following the original description of Barlow and Bosman 
(128,129), many studies addressed the syndrome of midsystolic click, late systolic 
murmur, and ballooning posterior mitral leaflet as a cause of distressing chest 
pain and life-threatening arrhythmias (86,90,96,101,124,130). More recently, 
because of the progressive disappearance of auscultation in the clinical setting 
(131), the role of midsystolic click as a marker of malignant MVP was overlooked. 
In our series, most of MVP patients with LGE had a midsystolic click on 
auscultation. Noteworthy, by reclassifying the population on the basis of presence 
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of midsystolic click, those with click had curling, LGE, and arrhythmias more 
frequently. In other words, MVP patients presenting with midsystolic click on 
auscultation, MAD, curling, and mitral annular abnormal contractility are those 
who need further evaluation for arrhythmic risk stratification through CMR. On 
the basis of our data, this auscultatory finding is likely because of the tension 
produced on the MV apparatus by the abnormal systolic curling (107). In light of 
these considerations, it is not surprisingly that in the early era of MVP, its 
diagnosis, being based on classical auscultatory findings, allowed the 
identification of patients with high prevalence of severe ventricular arrhythmias 
at risk of SCD (86,90,96,101,124,130). Arrhythmic MVP should be kept clearly 
distinct from the echocardiographic MVP, which is defined simply as single-leaflet 
or bileaflet prolapse of at least 2 mm beyond the long-axis annular plane. 
Although the latter is a relatively common condition with a benign behaviour 
(70,74,83,132,133), no data are available on the prevalence of the nosographic 
entity of arrhythmic MVP and further studies are needed. 
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Figure 18. Phisiopathological hypothesis underling tissue characterization in MVP patients. 
 
 
 
 
An association between MAD, curling, and LV fibrosis has been first 
detected by CMR in MVP patients with an arrhythmic malignant profile and then 
confirmed by histology in SCD patients with MVP. This unique annular 
morphology may account for the excessive mobility of the leaflets, as visualized 
by systolic curling and clinically suggested by auscultatory midsystolic click, and 
for the stretch-related myocardial remodelling of the inferobasal wall (Figure 18). 
Further studies are needed to confirm this hypothesis. 
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Chapter 7 
 
CONCLUSIONS   and  LIMITATIONS 
 
Cardiac magnetic resonance, due to its capability to provide both 
morphological, functional and tissue characterization information about any kind 
of heart disease “in vivo”, has become the linking between clinical issues and 
pathologist responses, allowing us to make diagnosis, suggesting hypothesis and 
making inference. 
As in hypertrophic cardiomyopathy, dilated cardiomyopathy and in ischemic 
heart disease where the prognostic role of CMR is widely recognize, we herein 
demonstrated its value also in other and less studied heart disease.  
We demonstrated as junctional fibrosis is not the classical myocardial scar and 
its association with higher LV filling pressure and/or right ventricular dysfunction 
make sense of its prognostic value for heart failure end point rather than 
ventricular arrhythmias.  
Moreover, understanding the anatomical substrates underlying electrical issues 
(i.e. negative T waves), allows us to make inference about their prognostic value. 
Herein we demonstrated that transmural myocardial edema is associated with 
negative T waves in acute myocarditis as in tako-tsubo cardiomyopathy. Because 
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of its transitory nature, we hypothesized and confirmed that negative T-waves 
doesn’t represent a marker of adverse remodeling in acute myocarditis (134) 
despite what are reported in literature. 
     
Finally we investigated the linking between MVP and arrhythmias, disclosing 
that MVP cannot be defined simply as an excursion of one or both mitral valve 
leaflet into left atrium but probably we need to come back to Barlow and Gilbert’s 
definition. An abnormal mitral insertion along the atrium-ventricular junction, the 
so called disjunction, perhaps associated with familiar/genetic predisposition, can 
be responsible of a non physiological leaflet protrusion into left atrium. This may 
lead to an abnormal valve and chordal progressive stretching that can be the 
responsible of a mixomatose valvular degeneration which perpetuates the vitium, 
according to Laplace theory. The chordae elongation yield the mid/late systolic 
click and the loss of coaptation of the billowing leaflet may produce the 
regurgitant murmur. The progressive development of “curling”, due to the weak 
disjunction, represent the most sensational sign of the valve prolapse, leading an 
impairment of muscular contraction in these point where the stress is bigger (i.e. 
the papillary muscle and its insertion point and the basal LV). The tissue stretched 
leads to myocardial fibrosis may represent an arrhythmogenic substrate for MVP 
(103,135). 
Some limitations about results are regarding the small population samples 
since the single center data. Further multicenter studies should be scheduled to 
confirm the conclusions obviously. On the other hand, the added value of these 
works is the closely relationship with in vivo and ex vivo findings: for what we 
explore in vivo by CMR, we find proofs in ex vivo pathologic studies. 
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APPENDIX 
 
Detailed CMR acquisition protocols 
- Dilated Cardiomyopathy Study (chapter 3): 
Functional assessment and kinetic images: steady-state free precession 
sequence (true FISP) cine loops in sequential short axis views (slice thickness 6 
mm, no gap; repetition time 2.5 to 3.8 ms; echo time 1.1 to 1.6 ms, average in-
plane resolution 1.5x2.4 mm, flip angle 45° to 60°, temporal resolution 40 to 45 
ms) and 3 long- axis views (2-chamber view, 3-chamber view, 4-chamber view). 
Post contrast images: intravenous administration of gadobenate 
dimeglumine (Multihance, Bracco, 0.2 mmol/kg of body weight). Two-
dimensional segmented fast low-angle shot inversion recovery sequence after at 
least 10 minutes were acquired in the same slices positions of cine images, 
covering the entire ventricles (repetition time 5.4 to 8.3 ms, echo time 1.3 to 3.9 
ms, average in-plane spatial resolution 1.4 to 1.5 x 2.2 to 2.4 mm, 6- mm slice 
thickness, no gap, and flip angle 20° to 25°). Inversion times were adjusted to null 
normal myocardium (typically 220-300 msec). Images were repeated in 2 
separate phase-encoding directions to exclude artefacts. 
 
- Acute Myocarditis study (chapter 4): 
Functional assessment and cinetic images: steady-state free precession 
sequence (true FISP) cine loops in sequential short axis views (slice thickness 6 
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mm, no gap; repetition time 2.5 to 3.8 ms; echo time 1.1 to 1.6 ms, average in-
plane resolution 1.5x2.4 mm, flip angle 45° to 60°, temporal resolution 40 to 45 
ms) and 3 long- axis views (2-chamber view, 3-chamber view, 4-chamber view). 
Detection of myocardial edema: triple inversion recovery (TIRM) sequences 
were applied before contrast administration and acquired at the same location of 
cine images. Long axis views (2-chamber view, 3-chamber view, 4-chamber view) 
and sequential short axis views (slice thickness 6 mm, no gap): echo time 61 ms, 
average in-plane resolution 1.5x2.5 mm, flip angle 180°) . 
Detection of early gadolinium enhancement: free-breathing black blood 
fast spin echo (FSE) T1-weighted sequence with an acquisition time of 3–4 min 
was acquired in four identical axial slices, both before and after (without any 
change in the parameters in between) intravascular injection of  contrast agent 
(gadobenate dimeglumine, Multihance, Bracco, 0.2 mmol/kg of body weight).  
Detection of LGE: ten minutes after intravenous administration of contrast 
agent 2-dimensional segmented fast low-angle shot inversion recovery sequences 
were acquired in the same views of cine images, covering the entire ventricles. 
Inversion times were adjusted to null normal myocardium using the Look-Locker 
sequence and images were repeated in 2 separate phase-encoding directions to 
exclude artefacts. 
 
- Mitral Valve Prolapse studies (chapter 5-6) 
Functional assessment and cinetic images: steady-state free precession 
sequence (true FISP) cine loops in sequential short axis views (slice thickness 6 
mm, no gap; repetition time 2.5 to 3.8 ms; echo time 1.1 to 1.6 ms, average in-
plane resolution 1.5x2.4 mm, flip angle 45° to 60°, temporal resolution 40 to 45 
ms) and 3 long- axis views (2-chamber view, 3-chamber view, 4-chamber view). 
Post contrast images: intravenous administration of gadobenate 
dimeglumine (Multihance, Bracco, 0.2 mmol/kg of body weight). Two-
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dimensional segmented fast low-angle shot inversion recovery sequence after at 
least 10 minutes were acquired in the same slices positions of cine images, 
covering the entire ventricles (repetition time 5.4 to 8.3 ms, echo time 1.3 to 3.9 
ms, average in-plane spatial resolution 1.4 to 1.5 x 2.2 to 2.4 mm, 6- mm slice 
thickness, no gap, and flip angle 20° to 25°). Inversion times were adjusted to null 
normal myocardium (typically 220-300 msec). Images were repeated in 2 
separate phase-encoding directions to exclude artefacts. 
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